<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Chem</journal-id><journal-id journal-id-type="iso-abbrev">BMC Chem</journal-id><journal-title-group><journal-title>BMC Chemistry</journal-title></journal-title-group><issn pub-type="epub">2661-801X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7818921</article-id><article-id pub-id-type="publisher-id">717</article-id><article-id pub-id-type="doi">10.1186/s13065-020-00717-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Synthesis and biological evaluation of heterocyclic 1,2,4-triazole scaffolds as promising pharmacological agents</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumari</surname><given-names>Mukesh</given-names></name><address><email>mukeshsuhag.71@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tahlan</surname><given-names>Sumit</given-names></name><address><email>sumittahlan1989@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Narasimhan</surname><given-names>Balasubramanian</given-names></name><address><email>naru2000us@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ramasamy</surname><given-names>Kalavathy</given-names></name><address><email>kalav922@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Lim</surname><given-names>Siong Meng</given-names></name><address><email>stvlsm@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Syed Adnan Ali</given-names></name><address><email>benzene301@yahoo.com</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Mani</surname><given-names>Vasudevan</given-names></name><address><email>vasumpharmacol@gmail.com</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kakkar</surname><given-names>Saloni</given-names></name><address><email>salonikakkar2007@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411524.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1790 2262</institution-id><institution>Faculty of Pharmaceutical Sciences, </institution><institution>Maharshi Dayanand University, </institution></institution-wrap>Rohtak, 124001 India </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412259.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2161 1343</institution-id><institution>Faculty of Pharmacy, </institution><institution>Universiti Teknologi MARA (UiTM), </institution></institution-wrap>42300 Bandar Puncak Alam, Selangor Darul Ehsan Malaysia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.412259.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2161 1343</institution-id><institution>Collaborative Drug Discovery Research (CDDR) Group, Pharmaceutical Life Sciences Community of Research, </institution><institution>Universiti Teknologi MARA (UiTM), </institution></institution-wrap>40450 Shah Alam, Selangor Darul Ehsan Malaysia </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.412259.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2161 1343</institution-id><institution>Atta-Ur-Rahman Institute for Natural Products Discovery (AuRIns), </institution><institution>Universiti Teknologi MARA (UiTM), </institution></institution-wrap>Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor Darul Ehsan Malaysia </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.412602.3</institution-id><institution-id institution-id-type="ISNI">0000 0000 9421 8094</institution-id><institution>Department of Pharmacology and Toxicology, College of Pharmacy, </institution><institution>Qassim University, </institution></institution-wrap>Buraidah, 51452 Kingdom of Saudi Arabia </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2021</year></pub-date><volume>15</volume><issue>1</issue><elocation-id>5</elocation-id><history><date date-type="received"><day>21</day><month>1</month><year>2020</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Triazole is an important heterocyclic moiety that occupies a unique position in heterocyclic chemistry, due to its large number of biological activities. It exists in two isomeric forms i.e. 1,2,4-triazole and 1,2,3-triazole and is used as core molecule for the design and synthesis of many medicinal compounds. 1,2,4-Triazole possess broad spectrum of therapeutically interesting drug candidates such as analgesic, antiseptic, antimicrobial, antioxidant, anti-<italic>urease</italic>, anti-inflammatory, diuretics, anticancer, anticonvulsant, antidiabetic and antimigraine agents.</p></sec><sec><title>Methods</title><p id="Par2">The structures of all synthesized compounds were characterized by physicochemical properties and spectral means (IR and NMR). The synthesized compounds were evaluated for their in vitro antimicrobial activity against Gram-positive (<italic>B. subtilis</italic>), Gram-negative (<italic>P. aeruginosa</italic> and <italic>E. coli</italic>) bacterial and fungal (<italic>C. albicans</italic> and <italic>A. niger</italic>) strains by tube dilution method using ciprofloxacin, amoxicillin and fluconazole as standards. In-vitro antioxidant and anti-<italic>urease</italic> screening was done by DPPH assay and indophenol method, respectively. The in-vitro anticancer evaluation was carried out against MCF-7 and HCT116 cancer cell lines using 5-FU as standards.</p></sec><sec><title>Results, discussion and conclusion</title><p id="Par3">The biological screening results reveal that the compounds <bold>T</bold><sub><bold>5</bold></sub> (MIC<sub><italic>BS</italic>, <italic>EC</italic></sub>&#x02009;=&#x02009;24.7&#x000a0;&#x000b5;M, MIC<sub><italic>PA</italic></sub>, <sub><italic>CA</italic></sub>&#x02009;=&#x02009;12.3&#x000a0;&#x000b5;M) and <bold>T</bold><sub><bold>17</bold></sub> (MIC<sub><italic>AN</italic></sub>&#x02009;=&#x02009;27.1&#x000a0;&#x000b5;M) exhibited potent antimicrobial activity as comparable to standards ciprofloxacin, amoxicillin (MIC<sub>Cipro</sub>&#x02009;=&#x02009;18.1&#x000a0;&#x000b5;M, MIC<sub>Amo</sub>&#x02009;=&#x02009;17.1&#x000a0;&#x000b5;M) and fluconazole (MIC<sub>Flu</sub>&#x02009;=&#x02009;20.4&#x000a0;&#x000b5;M), respectively. The antioxidant evaluation showed that compounds <bold>T</bold><sub><bold>2</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;34.83&#x000a0;&#x000b5;g/ml) and <bold>T</bold><sub><bold>3</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;34.38&#x000a0;&#x000b5;g/ml) showed significant antioxidant activity and comparable to ascorbic acid (IC<sub>50</sub>&#x02009;=&#x02009;35.44&#x000a0;&#x000b5;g/ml). Compounds <bold>T</bold><sub><bold>3</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;54.01&#x000a0;&#x000b5;g/ml) was the most potent <italic>urease</italic> inhibitor amongst the synthesized compounds and compared to standard thiourea (IC<sub>50</sub>&#x02009;=&#x02009;54.25&#x000a0;&#x000b5;g/ml). The most potent anticancer activity was shown by compounds <bold>T</bold><sub><bold>2</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;3.84&#x000a0;&#x003bc;M) and <bold>T</bold><sub><bold>7</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;3.25&#x000a0;&#x003bc;M) against HCT116 cell lines as compared to standard 5-FU (IC<sub>50</sub>&#x02009;=&#x02009;25.36&#x000a0;&#x003bc;M).</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>1,2,4-Triazole</kwd><kwd>Antimicrobial</kwd><kwd>Antioxidant</kwd><kwd>Anti-<italic>urease</italic></kwd><kwd>Anticancer</kwd><kwd>SAR</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par26">Triazole is an N-bridged aromatic heterocyclic compound that received a considerable attention in recent years due to their biological activities [<xref ref-type="bibr" rid="CR1">1</xref>]. The name &#x0201c;triazole&#x0201d; was first use by Bladin in 1855 for describing the carbon&#x02013;nitrogen ring system C<sub>2</sub>H<sub>3</sub>N<sub>3</sub> [<xref ref-type="bibr" rid="CR2">2</xref>]. It is a white to pale yellow crystalline solid with a weak, characteristic odour, soluble in water and alcohol, melts at 120&#x000a0;&#x000b0;C and boils at 260&#x000a0;&#x000b0;C [<xref ref-type="bibr" rid="CR3">3</xref>]. Triazole exists in two isomeric forms such as 1,2,4-triazole and 1,2,3-triazole [<xref ref-type="bibr" rid="CR4">4</xref>]. The SAR studies of triazole derivative reveals that substitution on positions 3, 4 and 5 of triazole ring can be varied but the greatest changed in physicochemical properties and biological profile is exerted by the groups attached to the nitrogen atom at the 4th position [<xref ref-type="bibr" rid="CR3">3</xref>]. It favours the hydrogen bonding and is also stable for metabolic degradation, which could be favorable in increasing solubility as well as in binding bimolecular targets [<xref ref-type="bibr" rid="CR5">5</xref>]. Novel triazole drugs discovered and developed by applying bioisosteric replacement technique with extending biological activities also captured a special attention in medicinal chemistry [<xref ref-type="bibr" rid="CR6">6</xref>]. Numerous medicines containing triazole moiety available in market (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) are: <italic>Antifungal</italic> [<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>]&#x02014;myclobutanil, tebuconazole, posaconazole, itraconazole fluconazole, paclobutrazole <italic>Anticancer</italic> [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]&#x02014;anastrazole, litrozole, vorozole, <italic>Antimigrain</italic> [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]&#x02014;rizatriptan and <italic>Antiviral</italic> [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]&#x02014;ribavirin.<fig id="Fig1"><label>Fig. 1</label><caption><p>Marketed preparations containing 1,2,4-triazole as core moiety</p></caption><graphic xlink:href="13065_2020_717_Fig1_HTML" id="MO1"/></fig></p><p id="Par27">At present time, our medical field is suffering from the problem of antimicrobial resistance towards many microbial strains. Hence as prioritized by various health organizations, there is a need for the discovery or development of novel antimicrobial compounds possessing a broad spectrum activity exhibiting high effectiveness against those highly resistant Gram positive, Gram negative bacterial and fungal strains [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par28">Human cells face threats everyday because the attack of various viruses, infections and free radicals damage the body cells and DNA. Scientists observed that the free radicals contribute to the ageing process and also contribute in diseases, like cancer, diabetes and heart disease. Antioxidants are the chemicals that stop or limit the damage caused by the free radicals and also boost our immunity [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par29"><italic>Ureases</italic> relate to the class of Urea amidohydrolases enzymes containing two nickel(II) atoms. <italic>Ureases</italic> are mainly obtained from plants, algae, fungi and bacteria. Bacterial <italic>ureases</italic> are responsible for causing many diseases like pyelonephritis, hepatic coma, peptic ulceration, urinary stones and stomach cancer. Rationally, A category of anti<italic>urease</italic> or <italic>urease</italic> inhibitory drugs was developed for curing the <italic>urease</italic> caused disease by inhibiting <italic>urease</italic> enzymes. The two nickel(II) atoms present in active site of <italic>Ureases</italic> accelerate the hydrolysis of urea into ammonia and carbon dioxide gas. Both CO<sub>2</sub> and NH<sub>3</sub> are important virulence factor for the pathogenesis of many above given clinical conditions. Anti-<italic>urease</italic> compounds inhibit the hydrolysis of urea by antagonising <italic>urease</italic> enzyme [<xref ref-type="bibr" rid="CR16">16</xref>]. This article also focuses on some new 1,2,4-triazole derivatives exhibiting anti-<italic>urease</italic> activity.</p><p id="Par30">Colorectal cancer is the third most lethal cancer worldwide in both males and females with drug resistance and metastasis being the major challenge to effective treatments. Maximum deaths due to colon cancer are related with metastatic ailment. The growth of colorectal cancer is promoted by epigenetic factors, such as abnormal DNA methylation. Targeted therapy is a kind of chemotherapy that specifically targets the proteins that resist the development of some cancers [<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par31">Palmitic acid (common name) is categorized as saturated fatty acid with chemical formula CH<sub>3</sub>(CH<sub>2</sub>)<sub>14</sub>COOH (IUPAC name: hexadecanoic acid). The main sources of palmitic acid are palm oil, olive oil, meats, cheese, cocoa butter, breast milk and dairy products [<xref ref-type="bibr" rid="CR18">18</xref>]. Napalm, is a derivative of palmitic acid, synthesized by the combination of aluminium salts of palmitic acid and naphthenic acid and it was used as fuel during World War II [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par32">1,2,4-Triazole attracts the attention of researchers due to its broad spectrum of biological activities (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) such as antimigrain [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], antioxidant [<xref ref-type="bibr" rid="CR15">15</xref>], anti-<italic>urease</italic> [<xref ref-type="bibr" rid="CR16">16</xref>], antimicrobial [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], anti-inflammatory [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], anticonvulsant [<xref ref-type="bibr" rid="CR23">23</xref>], anticancer [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], antiviral [<xref ref-type="bibr" rid="CR25">25</xref>] and antiparasytic [<xref ref-type="bibr" rid="CR25">25</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>Design of 1,2,4-triazole analogues for antimicrobial, antioxidant, anti<italic>urease</italic> and anticancer activities based on biological profile</p></caption><graphic xlink:href="13065_2020_717_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec14"><title>Results and discussion</title><sec id="Sec15"><title>Chemistry</title><p id="Par46">The multistep synthetic process of 1,2,4-triazole derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>) was depicted in Scheme <xref rid="Sch1" ref-type="fig">1</xref>. Initially, ethylpalmitate (<bold>Int-i</bold>) was synthesized by the reaction of palmitic acid, ethanol and sulphuric acid. Palmitohydrazide (<bold>Int-ii</bold>) was synthesized from ethanolic solution of ethylpalmitate (<bold>Int-i</bold>) followed by addition of hydrazine hydrate. 5-Pentadecyl-1,3,4-oxadiazole-2(3<italic>H</italic>)-thione (<bold>Int-iii</bold>) was synthesized using <bold>Int-ii</bold> in alc. potassium hydroxide solution followed by the addition of carbon disulfide and then followed by addition of hydrazine hydrate to <bold>Int-iii</bold> yielded 4-amino-5-pentadecyl-4<italic>H</italic>-1,2,4-triazole-3-thiol (<bold>Int-iv</bold>). Finally, the <bold>Int-iv</bold> on reaction with different substituted aromatic aldehydes in ethanol yielded the title compounds (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>). The physicochemical properties of the synthesized compounds are depicted in Table <xref rid="Tab1" ref-type="table">1</xref>. The synthesized derivatives of 1,2,4-triazole were confirmed by Infrared (IR) and Nuclear Magnetic Resonance (<sup>1</sup>H/<sup>13</sup>CNMR). The spectro-analytical data has been depicted in Table <xref rid="Tab2" ref-type="table">2</xref>. The presence of aliphatic &#x02013;CH&#x02013; stretch in all compounds was confirmed at 2990&#x02013;2879&#x000a0;cm<sup>&#x02212;1</sup>. The intermediates (<bold>Int-ii</bold>, <bold>iii</bold> and <bold>iv</bold>) exhibited the &#x02013;NH stretch in range of 3424&#x02013;3319&#x000a0;cm<sup>&#x02212;1</sup>. The presence of &#x02013;CONH&#x02013; group in <bold>Int</bold>-<bold>ii</bold> was indicated by appearance of &#x02013;CONH&#x02013; stretch at 1630&#x000a0;cm<sup>&#x02212;1</sup>. The peak range 1677&#x02013;1589&#x000a0;cm<sup>&#x02212;1</sup> in <bold>Int-iii</bold>, <bold>iv</bold> and compounds <bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub> indicated the presence of &#x02013;C=N stretch. The presence of &#x02013;SH stretching vibrations in <bold>Int-iv</bold> and compounds <bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub> were indicated in a scale of 2593&#x02013;2505&#x000a0;cm<sup>&#x02212;1</sup>. The compounds <bold>T</bold><sub><bold>4</bold></sub>, <bold>T</bold><sub><bold>5</bold></sub> and <bold>T</bold><sub><bold>6</bold></sub> showed the &#x02013;OCH<sub>3</sub> stretching vibrations in the range of 2860&#x02013;2848&#x000a0;cm<sup>&#x02212;1</sup>. The presence of phenolic group in compounds <bold>T</bold><sub><bold>6</bold></sub>, <bold>T</bold><sub><bold>7</bold></sub>, <bold>T</bold><sub><bold>8</bold></sub> and <bold>T</bold><sub><bold>18</bold></sub> was indicated by peaks in the range of 3483&#x02013;3400&#x000a0;cm<sup>&#x02212;1</sup>. The peak range 701&#x02013;699&#x000a0;cm<sup>&#x02212;1</sup> of compounds <bold>T</bold><sub><bold>13</bold></sub> and <bold>T</bold><sub><bold>14</bold></sub> was indicated the presence of Ar&#x02013;Br group. The compounds <bold>T</bold><sub><bold>15</bold></sub>, <bold>T</bold><sub><bold>16</bold></sub> and <bold>T</bold><sub><bold>17</bold></sub> showed the Ar&#x02013;NO<sub>2</sub> stretching vibrations in the range of 1545&#x02013;1424&#x000a0;cm<sup>&#x02212;1</sup>. The presence of Ar&#x02013;Cl group in compounds <bold>T</bold><sub><bold>10</bold></sub>, <bold>T</bold><sub><bold>11</bold></sub> and <bold>T</bold><sub><bold>12</bold></sub> was confirmed by the appearance of peaks in the range of 767&#x02013;750&#x000a0;cm<sup>&#x02212;1</sup>. The presence of tertiary amine in compound <bold>T</bold><sub><bold>9</bold></sub> was confirmed by the appearance of peak at 3431&#x000a0;cm<sup>&#x02212;1</sup>. The presence of aromatic ring in compounds <bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub> was indicated by the appearance of peak in the range of 1796&#x02013;1719&#x000a0;cm<sup>&#x02212;1</sup>. DMSO was used as solvent for the analysis of compounds by <sup>1</sup>HNMR spectra. The presence of singlet signal at 1.22&#x02013;2.47 &#x003b4; ppm and 0.82&#x02013;0.84 &#x003b4; ppm indicated the presence of protons of &#x02013;CH<sub>2</sub> and &#x02013;CH<sub>3</sub> groups in <bold>Int-ii</bold>, <bold>iii</bold> and <bold>iv</bold>, respectively. Singlet at 2.25 &#x003b4; ppm and 8.87 &#x003b4; ppm showed the presence of protons of NH<sub>2</sub> and NH groups in <bold>Int</bold>-<bold>ii</bold>, <bold>iii</bold> and <bold>iv</bold>, respectively. The presence of proton of SH group was indicated by appearance of singlet at 3.30 in <bold>Int</bold>-<bold>iv</bold>. The findings of elemental analysis of synthesized derivatives were recorded within theoretical results of &#x000b1;&#x02009;0.4%. Mass spectra of the synthesized derivatives reflected the characteristic molecular ion peaks.<fig id="Sch1"><label>Scheme 1.</label><caption><p>Synthesis of 1,2,4-triazole derivatives</p></caption><graphic xlink:href="13065_2020_717_Sch1_HTML" id="MO14"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Physicochemical characterization of synthesized derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub><bold>)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Comp</th><th align="left">Mol. formula</th><th align="left">Mol. wt</th><th align="left">Colour</th><th align="left">M.p. (&#x000b0;C)</th><th align="left">Rf value</th><th align="left">% Yield</th></tr></thead><tbody><tr><td align="left"><bold>Int-ii</bold></td><td align="left">C<sub>18</sub>H<sub>36</sub>O</td><td char="." align="char">284.84</td><td align="left">White</td><td align="left">121&#x02013;124</td><td char="." align="char">0.37<sup>a</sup></td><td char="." align="char">71.0</td></tr><tr><td align="left"><bold>Int-iii</bold></td><td align="left">C<sub>17</sub>H<sub>31</sub>N<sub>2</sub>OS</td><td char="." align="char">312.51</td><td align="left">Yellow</td><td align="left">154&#x02013;157</td><td char="." align="char">0.42<sup>a</sup></td><td char="." align="char">52.1</td></tr><tr><td align="left"><bold>Int-iv</bold></td><td align="left">C<sub>17</sub>H<sub>34</sub>N<sub>4</sub>S</td><td char="." align="char">326.54</td><td align="left">Pinkish white</td><td align="left">178&#x02013;181</td><td char="." align="char">0.41<sup>b</sup></td><td char="." align="char">46.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>1</bold></sub></td><td align="left">C<sub>24</sub>H<sub>38</sub>N<sub>4</sub>S</td><td char="." align="char">414.65</td><td align="left">Creamish white</td><td align="left">184&#x02013;187</td><td char="." align="char">0.40<sup>b</sup></td><td char="." align="char">78.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>2</bold></sub></td><td align="left">C<sub>25</sub>H<sub>38</sub>N<sub>4</sub>OS</td><td char="." align="char">442.66</td><td align="left">Light brown</td><td align="left">182&#x02013;185</td><td char="." align="char">0.33<sup>b</sup></td><td char="." align="char">82.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>3</bold></sub></td><td align="left">C<sub>25</sub>H<sub>40</sub>N<sub>4</sub>S</td><td char="." align="char">428.68</td><td align="left">Yellowish white</td><td align="left">190&#x02013;193</td><td char="." align="char">0.52<sup>b</sup></td><td char="." align="char">74.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>4</bold></sub></td><td align="left">C<sub>26</sub>H<sub>43</sub>N<sub>4</sub>O<sub>2</sub>S</td><td char="." align="char">474.70</td><td align="left">White</td><td align="left">188&#x02013;191</td><td char="." align="char">0.60<sup>b</sup></td><td char="." align="char">85.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>5</bold></sub></td><td align="left">C<sub>27</sub>H<sub>44</sub>N<sub>4</sub>O<sub>3</sub>S</td><td char="." align="char">504.73</td><td align="left">Yellow</td><td align="left">187&#x02013;190</td><td char="." align="char">0.38<sup>b</sup></td><td char="." align="char">79.5</td></tr><tr><td align="left"><bold>T</bold><sub><bold>6</bold></sub></td><td align="left">C<sub>25</sub>H<sub>40</sub>N<sub>4</sub>O<sub>2</sub>S</td><td char="." align="char">460.68</td><td align="left">Creamish white</td><td align="left">189&#x02013;192</td><td char="." align="char">0.49<sup>b</sup></td><td char="." align="char">84.6</td></tr><tr><td align="left"><bold>T</bold><sub><bold>7</bold></sub></td><td align="left">C<sub>24</sub>H<sub>38</sub>N<sub>4</sub>OS</td><td char="." align="char">430.65</td><td align="left">Lemon yellow</td><td align="left">181&#x02013;184</td><td char="." align="char">0.32<sup>b</sup></td><td char="." align="char">78.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>8</bold></sub></td><td align="left">C<sub>24</sub>H<sub>38</sub>N<sub>4</sub>OS</td><td char="." align="char">430.65</td><td align="left">Greenish white</td><td align="left">192&#x02013;195</td><td char="." align="char">0.73<sup>b</sup></td><td char="." align="char">65.9</td></tr><tr><td align="left"><bold>T</bold><sub><bold>9</bold></sub></td><td align="left">C<sub>26</sub>H<sub>43</sub>N<sub>5</sub>S</td><td char="." align="char">457.72</td><td align="left">Green</td><td align="left">198&#x02013;201</td><td char="." align="char">0.62<sup>b</sup></td><td char="." align="char">75.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>10</bold></sub></td><td align="left">C<sub>24</sub>H<sub>37</sub>ClN<sub>4</sub>S</td><td char="." align="char">449.10</td><td align="left">Pinkish white</td><td align="left">205&#x02013;208</td><td char="." align="char">0.59<sup>b</sup></td><td char="." align="char">79.6</td></tr><tr><td align="left"><bold>T</bold><sub><bold>11</bold></sub></td><td align="left">C<sub>24</sub>H<sub>37</sub>ClN<sub>4</sub>S</td><td char="." align="char">449.10</td><td align="left">White</td><td align="left">202&#x02013;205</td><td char="." align="char">0.65<sup>b</sup></td><td char="." align="char">78.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>12</bold></sub></td><td align="left">C<sub>24</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>4</sub>S</td><td char="." align="char">483.54</td><td align="left">White</td><td align="left">211&#x02013;214</td><td char="." align="char">0.34<sup>b</sup></td><td char="." align="char">74.3</td></tr><tr><td align="left"><bold>T</bold><sub><bold>13</bold></sub></td><td align="left">C<sub>24</sub>H<sub>37</sub>BrN<sub>4</sub>S</td><td char="." align="char">493.55</td><td align="left">White</td><td align="left">197&#x02013;200</td><td char="." align="char">0.39<sup>b</sup></td><td char="." align="char">89.2</td></tr><tr><td align="left"><bold>T</bold><sub><bold>14</bold></sub></td><td align="left">C<sub>24</sub>H<sub>37</sub>BrN<sub>4</sub>S</td><td char="." align="char">493.55</td><td align="left">Brownish yellow</td><td align="left">193&#x02013;196</td><td char="." align="char">0.71<sup>b</sup></td><td char="." align="char">85.8</td></tr><tr><td align="left"><bold>T</bold><sub><bold>15</bold></sub></td><td align="left">C<sub>24</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>S</td><td char="." align="char">459.65</td><td align="left">Mustard yellow</td><td align="left">195&#x02013;198</td><td char="." align="char">0.68<sup>b</sup></td><td char="." align="char">78.9</td></tr><tr><td align="left"><bold>T</bold><sub><bold>16</bold></sub></td><td align="left">C<sub>24</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>S</td><td char="." align="char">459.65</td><td align="left">Dark yellow</td><td align="left">199&#x02013;202</td><td char="." align="char">0.45<sup>b</sup></td><td char="." align="char">90.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>17</bold></sub></td><td align="left">C<sub>24</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>S</td><td char="." align="char">459.65</td><td align="left">Brown</td><td align="left">206&#x02013;209</td><td char="." align="char">0.50<sup>b</sup></td><td char="." align="char">85.8</td></tr><tr><td align="left"><bold>T</bold><sub><bold>18</bold></sub></td><td align="left">C<sub>28</sub>H<sub>40</sub>N<sub>4</sub>OS</td><td char="." align="char">480.71</td><td align="left">Red</td><td align="left">186&#x02013;189</td><td char="." align="char">0.67<sup>b</sup></td><td char="." align="char">88.8</td></tr><tr><td align="left"><bold>T</bold><sub><bold>19</bold></sub></td><td align="left">C<sub>26</sub>H<sub>40</sub>N<sub>4</sub>OS</td><td char="." align="char">440.69</td><td align="left">Creamish white</td><td align="left">179&#x02013;182</td><td char="." align="char">0.24<sup>b</sup></td><td char="." align="char">87.9</td></tr><tr><td align="left"><bold>T</bold><sub><bold>20</bold></sub></td><td align="left">C<sub>22</sub>H<sub>36</sub>N<sub>4</sub>OS</td><td char="." align="char">404.61</td><td align="left">White</td><td align="left">196&#x02013;199</td><td char="." align="char">0.43<sup>b</sup></td><td char="." align="char">87.0</td></tr></tbody></table><table-wrap-foot><p>Mobile phase: <sup>a</sup>[chloroform:toluene, 7:3], <sup>b</sup>[ethylacetate:<italic>n</italic>-hexane, 2:3]</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Spectral characterization of synthesized derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Comp</th><th align="left">IR (KBr, cm<sup>&#x02212;1</sup>)</th><th align="left"><sup>1</sup>H NMR (400&#x000a0;MHz, DMSO-<italic>d</italic><sub><italic>6</italic></sub>)</th><th align="left"><sup>13</sup>C NMR (400&#x000a0;MHz, DMSO-<italic>d</italic><sub><italic>6</italic></sub>)</th><th align="left">C, H, N analyses calculated (found); MS, ES&#x02009;+&#x02009;(ToF): <italic>m/z</italic>&#x02014;[M<sup>+</sup>&#x02009;+&#x02009;1]</th></tr></thead><tbody><tr><td align="left"><bold>Int-ii</bold></td><td align="left">3319&#x02013;3179 (N&#x02013;H str.), 2920 (C&#x02013;H str. aliphatic), 1739 (C=O str.)</td><td align="left">1.22&#x02013;2.24 (m, 28H, CH<sub>2</sub>), 0.83 (s, 3H, CH<sub>3</sub>), 2.5 (s, 2H, NH<sub>2</sub>), 8.873 (s, 1H, NH)</td><td align="left">14.0, 19.4, 29.4, 39.1, 128.9, 149.9, 168.6, 189.4</td><td align="left">C, 71.06; H, 12.67; N, 10.36; (C, 71.01; H, 12.57; N, 10.26); 271</td></tr><tr><td align="left"><bold>Int-iii</bold></td><td align="left">3424 (N&#x02013;H str.), 2921 (C&#x02013;H str. aliphatic), 1372 (C=S str.), 1589 (C=N str.), 1115 (C&#x02013;O str.)</td><td align="left">1.22&#x02013;2.47 (m, 28H, CH<sub>2</sub>), 0.84 (s, 3H, CH<sub>3</sub>)</td><td align="left">15.7, 18.7, 29.8, 37.1, 124.1, 149.9, 160.6, 182.4</td><td align="left">C, 65.34; H, 10.32; N, 8.96; (C, 65.31; H, 10.29; N, 8.91); 313</td></tr><tr><td align="left"><bold>Int-iv</bold></td><td align="left">3319 (N&#x02013;H str.), 2919 (C&#x02013;H str., aliphatic), 1631 (C=N str.), 2572 (S&#x02013;H str.)</td><td align="left">1.22&#x02013;2.12 (m, 28H, CH<sub>2</sub>), 0.82 (s, 3H, CH<sub>3</sub>), 2.51 (s, 2H, NH<sub>2</sub>), 8.87 (s, 1H, NH)</td><td align="left">17.7, 18.4, 29.8, 39.6, 128.1, 124.98, 149.9, 168.6, 188.4</td><td align="left">C, 62.53; H, 10.49; N, 17.16; (C, 62.50; H, 10.42; N, 17.12); 327</td></tr><tr><td align="left"><bold>T</bold><sub><bold>1</bold></sub></td><td align="left">2925 (C&#x02013;H str., aliphatic), 1625 (C=N str.), 3100 (C=C str., aromatic), 1719 (C&#x02013;H str., aromatic.), 2568 (S&#x02013;H str.)</td><td align="left">1.24&#x02013;2.45 (m, 28H, CH<sub>2</sub>), 0.84 (s, 3H, CH<sub>3</sub>), 7.41&#x02013;7.93 (m, 5H, Ar&#x02013;H), 3.37 (s, H, SH)</td><td align="left">15.0, 18.4, 29.1, 39.1, 124.1, 128.98, 148.9, 160.6, 182.4</td><td align="left">C, 69.52; H, 9.24; N, 13.51; (C, 69.49; H, 9.22; N, 13.49); 415</td></tr><tr><td align="left"><bold>T</bold><sub><bold>2</bold></sub></td><td align="left">2990 (C&#x02013;H str., aliphatic), 1646 (C=N str.), 1751 (C=O, str.), 1641 (C=C str., aromatic), 3073 (C&#x02013;H str., aromatic), 2572 (S&#x02013;H str.)</td><td align="left">1.32&#x02013;2.51 (m, 28H, CH<sub>2</sub>), 0.86 (s, 3H, CH<sub>3</sub>), 2.51 (s, 2H, CH<sub>2</sub>), 7.08&#x02013;7.91 (m, 4H, Ar&#x02013;H), 3.37 (s, H, SH), 10.02 (s, H, CHO)</td><td align="left">13.8, 22.0, 28.5&#x02013;28.9, 31.2, 129.8, 139.8, 140.9, 174.6, 192.4</td><td align="left">C, 67.83; H, 8.65; N, 12.66; (C, 67.80; H, 8.61; N, 12.62); 443</td></tr><tr><td align="left"><bold>T</bold><sub><bold>3</bold></sub></td><td align="left">2922 (C&#x02013;H str., aliphatic), 1649 (C=N str.), 1646 (C=C str., aromatic), 3098 (C&#x02013;H str., aromatic), 1790 (ring, str.), 2560 (S&#x02013;H str.)</td><td align="left">1.29&#x02013;2.51 (m, 24H, CH<sub>2</sub>), 0.87 (s, 3H, CH<sub>3</sub>), 7.30 (s, H, =CH), 7.51&#x02013;7.62 (m, 4H, Ar&#x02013;H), 3.37 (s, H, SH), 2.34 (s, 3H, Ar&#x02013;CH<sub>3</sub>)</td><td align="left">13.8, 22.0, 24.4, 28.5&#x02013;28.8, 31.2, 128.6, 129.7, 142.3, 161.11</td><td align="left">C, 70.05; H, 9.41; N, 13.07 (C, 70.00; H, 9.38; N, 13.02); 429</td></tr><tr><td align="left"><bold>T</bold><sub><bold>4</bold></sub></td><td align="left">2920 (C&#x02013;H str., aliphatic), 1631 (C=N str.), 2856 (C&#x02013;O&#x02013;C str.), 1647 (C=C str., aromatic), 3105 (C&#x02013;H str., aromatic), 2593 (S&#x02013;H str)</td><td align="left">1.26&#x02013;2.51 (m, 28H, CH<sub>2</sub>), 0.86 (s, 3H, CH<sub>3</sub>), 7.90 (s, H, =CH), 7.01&#x02013;7.61 (m, 3H, Ar&#x02013;H), 3.11 (s, H, SH), 3.76 (s, 6H, Ar&#x02013;OCH<sub>3</sub>)</td><td align="left">13.8, 22.0, 28.3&#x02013;28.9, 31.2, 55.1, 111.1, 149.1, 176.0</td><td align="left">C, 65.78; H, 8.92; N, 11.80; (C, 65.72; H, 8.89; N, 11.78; O, 6.70); 475</td></tr><tr><td align="left"><bold>T</bold><sub><bold>5</bold></sub></td><td align="left">2923 (C&#x02013;H str., aliphatic), 1639 (C=N str.), 2860 (C&#x02013;O&#x02013;C str.), 1450 (C=C str., aromatic), 3078 (C&#x02013;H str., aromatic), 2572 (S&#x02013;H str.)</td><td align="left">1.23&#x02013;2.47 (m, 28H, CH<sub>2</sub>), 0.85 (s, 3H, CH<sub>3</sub>), 7.21 (s, H, =CH), 7.10&#x02013;7.27 (m, 2H, Ar&#x02013;H), 3.52 (s, H, SH), 3.76 (s, 9H, Ar&#x02013;OCH<sub>3</sub>)</td><td align="left">14.0, 39.1, 105.6, 129.2, 140.2, 153.1, 161.1</td><td align="left">C, 64.25; H, 8.79; N, 11.10; (C, 64.21; H, 8.75; N, 11.08); 505</td></tr><tr><td align="left"><bold>T</bold><sub><bold>6</bold></sub></td><td align="left">2988 (C&#x02013;H str., aliphatic), 1677 (C=N str.), 1715 (ring, str.), 3400 (O&#x02013;H str.), 2843 (C&#x02013;O&#x02013;C str.), 1636 (C=C str., aromatic), 3154 (C&#x02013;H str., aromatic), 2555 (S&#x02013;H str.)</td><td align="left">1.21&#x02013;2.46 (m, 28H, CH<sub>2</sub>), 0.96 (s, 3H, CH<sub>3</sub>), 8.0 (s, H,CH), 7.51&#x02013;7.69 (m, 3H, Ar&#x02013;H), 3.37 (s, H, SH), 6.71 (s, H, OH), 3.79 (s, H, Ar&#x02013;OCH<sub>3</sub>)</td><td align="left">13.8, 22.0, 28.5&#x02013;28.9, 31.8, 55.5, 115.3, 120.7, 128.7, 142.7, 146.2, 168.2</td><td align="left">C, 65.18; H, 8.75; N, 12.16; (C, 65.13; H, 8.78; N, 12.15); 461</td></tr><tr><td align="left"><bold>T</bold><sub><bold>7</bold></sub></td><td align="left">2923 (C&#x02013;H str., aliphatic), 1617 (C=N str.), 3401(O&#x02013;H, str.), 1632 (C=C str., aromatic), 3101 (C&#x02013;H str., aromatic), 2695 (S&#x02013;H str.)</td><td align="left">1.27&#x02013;2.52 (m, 28H, CH<sub>2</sub>), 0.85 (s, 3H, CH<sub>3</sub>), 8.35 (s, H, =CH), 7.31&#x02013;7.79&#x000a0;m, 4H, Ar&#x02013;H), 3.37 (s, H, SH), 4.05 (s, H, OH)</td><td align="left">14.0, 15.0, 24.4, 29.0, 31.2, 33.9, 39.9, 59.9, 61.1, 116.6, 129.4, 157.06, 162.7</td><td align="left">C, 66.94; H, 8.89; N, 13.01; (C, 66.90; H, 8.83; N, 12.9); 431</td></tr><tr><td align="left"><bold>T</bold><sub><bold>8</bold></sub></td><td align="left">2919 (C&#x02013;H str., aliphatic), 1686 (C=N str.), 3483 (O&#x02013;H, str.), 1665 (C=C str., aromatic), 3098 (C&#x02013;H str., aromatic), 2572 (S&#x02013;H str.)</td><td align="left">1.28&#x02013;2.53 (m, 28H, CH<sub>2</sub>), 0.88 (s, 3H, CH<sub>3</sub>), 8.10 (s, H, =CH), 6.43&#x02013;7.49 (m, 4H, Ar&#x02013;H), 3.37 (s, H, SH), 5.01 (s, H, OH)</td><td align="left">14.3, 24.7, 29.0, 31.6, 34.1, 39.9, 46.2, 116.2, 129.1, 160, 175, 191.5</td><td align="left">C, 66.94; H, 8.89; N, 13.01; (C, 66.90; H, 8.85; N, 12.89); 431</td></tr><tr><td align="left"><bold>T</bold><sub><bold>9</bold></sub></td><td align="left">2925 (C&#x02013;H str., aliphatic), 1684 (C=N str.), 1645 (C=C str., aromatic), 3097 (C&#x02013;H str., aromatic), 3431 (N&#x02013;H amine, str.) 2572 (S&#x02013;H str.)</td><td align="left">1.21&#x02013;2.51 (m, 28H, CH<sub>2</sub>), 0.85 (s, 3H, CH<sub>3</sub>), 7.11&#x02013;7.48 (m, 4H, Ar&#x02013;H), 8.12 (s, H, =CH), 3.01 (s, H, SH), 2.99 (s, 6H, N&#x02013;(CH<sub>3</sub>)<sub>2</sub>)</td><td align="left">13.8, 22.0, 24.4, 29.0, 31.2, 46.3, 57.6, 118.7, 124.9, 128.1, 130.1, 134.9, 168.1, 114.4</td><td align="left">C, 68.23; H, 9.47; N, 15.30 (C, 68.20; H, 9.42; N, 15.27);458</td></tr><tr><td align="left"><bold>T</bold><sub><bold>10</bold></sub></td><td align="left">2916 (C&#x02013;H str., aliphatic), 1650 (C=N str.), 1456 (C=C str., aromatic), 3065 (C&#x02013;H str., aromatic), 750 (C&#x02013;Cl str.), 2567 (S&#x02013;H str.)</td><td align="left">1.24&#x02013;2.45 (m, 28H, CH<sub>2</sub>), 0.85 (s, 3H, CH<sub>3</sub>), 8.01 (s, H, =CH), 6.80&#x02013;7.61 (m, 4H, Ar&#x02013;H), 3.0 (s, H, SH)</td><td align="left">14.2, 22.2, 24.5, 29.4, 31.0, 46.3, 57.6, 118.7, 128.1, 130.1, 134.9, 148, 168.1</td><td align="left">C, 64.19; H, 8.30; N, 12.48; (C, 64.15; H, 8.28; N, 12.43); 449</td></tr><tr><td align="left"><bold>T</bold><sub><bold>11</bold></sub></td><td align="left">2916 (C&#x02013;H str., aliphatic), 1650 (C=N str.), 1635 (C=C str., aromatic), 3105 (C&#x02013;H str., aromatic), 767 (C&#x02013;Cl str.), 2572 (S&#x02013;H str.)</td><td align="left">1.26&#x02013;2.56 (s, 28H, CH<sub>2</sub>), 0.87 (s, 3H, CH<sub>3</sub>), 8.01 (s, H, =CH), 6.90&#x02013;7.68 (m, 4H, Ar&#x02013;H), 3.2 (s, H, SH)</td><td align="left">14.1, 22.0, 24.2, 29.9, 31.9, 40.3, 55.6, 118.7, 128.1, 131.1, 137.9, 148.9, 168.8</td><td align="left">C, 64.19; H, 8.30; N, 12.48; (C, 64.15; H, 8.27; N, 12.43); 449</td></tr><tr><td align="left"><bold>T</bold><sub><bold>12</bold></sub></td><td align="left">2905 (C&#x02013;H str., aliphatic), 1678.98 (C=N str.), 1604 (C=C str., aromatic), 3087 (C&#x02013;H str., aromatic), 767 (C&#x02013;Cl str.), 2505 (S&#x02013;H str.)</td><td align="left">1.23&#x02013;2.51 (m, 28H, CH<sub>2</sub>), 0.86 (s, 3H, CH<sub>3</sub>), 8.10 (s, H, =CH), 6.60&#x02013;7.57 (m, 3H, Ar&#x02013;H), 3.07 (s, H, SH)</td><td align="left">13.9, 22.5, 24.4, 29.9, 31.5, 44.3, 57.6, 119.7, 127.1, 131.9, 139.9, 148.9, 168.9</td><td align="left">C, 59.61; H, 7.50; N, 11.59; (C, 59.58; H, 7.48; N, 11.53); 483</td></tr><tr><td align="left"><bold>T</bold><sub><bold>13</bold></sub></td><td align="left">2919 (C&#x02013;H str., aliphatic), 1648 (C=N str.), 1624 (C=C str., aromatic), 3109 (C&#x02013;H str., aromatic), 699 (C&#x02013;Br str.), 2505 (S&#x02013;H str)]</td><td align="left">1.29&#x02013;0.55 (m, 28H, CH<sub>2</sub>), 0.87 (s, 3H, CH<sub>3</sub>), 8.12 (s, H, =CH), 6.98&#x02013;7.65 (m, 4H, Ar&#x02013;H), 3.02 (s, H, SH)</td><td align="left">14.4, 23.2, 24.0, 29.9, 33.3, 48.3, 59.6, 118.7, 128.9, 130.9, 134.8, 148.7, 168.6</td><td align="left">C, 58.41; H, 7.56; N, 11.35; (C, 58.41; H, 7.56; N, 11.35); 495</td></tr><tr><td align="left"><bold>T</bold><sub><bold>14</bold></sub></td><td align="left">2919 (C&#x02013;H str., aliphatic), 1648 (C=N str.), 1498 (C=C str., aromatic), 3054 (C&#x02013;H str., aromatic), 699 (C&#x02013;Br str.), 2505 (S&#x02013;H str)</td><td align="left">1.29&#x02013;2.59 (m, 28H, CH<sub>2</sub>), 0.88 (s, 3H, CH<sub>3</sub>), 8.98 (s, H, =CH), 6.50&#x02013;7.68 (m, 4H, Ar&#x02013;H), 3.09 (s, H, SH)</td><td align="left">15.4, 23.8, 24.9, 29.9, 33.0, 47.3, 56.6, 116.7, 129.9, 131.2, 134.8, 148.8, 168.9</td><td align="left">C, 58.41; H, 7.56; N, 11.35; (C, 58.39; H, 7.53; N, 11.30); 495</td></tr><tr><td align="left"><bold>T</bold><sub><bold>15</bold></sub></td><td align="left">2921 (C&#x02013;H str., aliphatic), 1698 (C=N str.), 1445 (C=C str., aromatic), 3100 (C&#x02013;H str., aromatic), 1545 (NO<sub>2</sub> str.), 2529 (S&#x02013;H str.)</td><td align="left">1.29&#x02013;2.67 (m, 28H, CH<sub>2</sub>), 0.87 (s, 3H, CH<sub>3</sub>), 8.02 (s, H, =CH), 7.51&#x02013;7.64 (m, 4H, Ar&#x02013;H), 3.07 (s, H, SH),</td><td align="left">13.4, 23.7, 24.5, 29.9, 32.3, 48.6, 59.8, 118.9, 127.9, 131.9, 134.9, 148.7, 168.5</td><td align="left">C, 62.71; H, 8.11; N, 15.24; (C, 62.69; H, 8.09; N, 15.20); 460</td></tr><tr><td align="left"><bold>T</bold><sub><bold>16</bold></sub></td><td align="left">2878 (C&#x02013;H str., aliphatic), 1648 (C=N str.), 1646 (C=C str., aromatic), 3045 (C&#x02013;H str., aromatic), 1424 (NO<sub>2</sub> str.), 2572 (S&#x02013;H str.)</td><td align="left">1.29&#x02013;2.51 (m, 28H, CH<sub>2</sub>), 0.87 (s, 3H, CH<sub>3</sub>), 8.01 (s, H, CH), 7.51&#x02013;7.96 (m, 4H, Ar&#x02013;H), 3.37 (s, H, SH), 2.34 (s, 3H, Ar&#x02013;CH<sub>3</sub>)</td><td align="left">13.4, 23.7, 24.5, 29.9, 32.3, 48.6, 59.8, 118.9, 127.9, 131.9, 134.9, 148.7</td><td align="left">C, 62.71; H, 8.11; N, 15.24; (C, 62.68; H, 8.07; N, 15.19); 460</td></tr><tr><td align="left"><bold>T</bold><sub><bold>17</bold></sub></td><td align="left">2880 (C&#x02013;H str., aliphatic), 1647 (C=N str.), 1498 (C=C str., aromatic), 3076 (C&#x02013;H str., aromatic), 1520 (NO<sub>2</sub> str.), 2572(S&#x02013;H str.)</td><td align="left">1.24&#x02013;2.56 (m, 28H, CH<sub>2</sub>), 0.86 (s, 3H, CH<sub>3</sub>), 8.31 (s, H, =CH), 6.90&#x02013;7.76 (m, 4H, Ar&#x02013;H), 3.07 (s, H, SH)</td><td align="left">14.4, 23.9, 24.7, 29.8, 31.3, 48.6, 57.8, 116.9, 127.9, 131.7, 135.9, 148.9, 168.3</td><td align="left">C, 62.71; H, 8.11; N, 15.24; (C, 62.68; H, 8.10; N, 15.22); 460</td></tr><tr><td align="left"><bold>T</bold><sub><bold>18</bold></sub></td><td align="left">2880 (C&#x02013;H str., aliphatic), 1650 (C=N str.), 1608 (C=C str., aromatic), 3109 (C&#x02013;H str., aromatic), 3401 (O&#x02013;H str.), 2572 (S&#x02013;H str.)</td><td align="left">1.29&#x02013;2.98 (m, 28H, CH<sub>2</sub>), 0.87 (s, 3H, CH<sub>3</sub>), 8.01 (s, H, =CH), 6.88&#x02013;8.08 (m, 6H, Ar&#x02013;H), 3.07 (s, H, SH), 5.01 (s, H, Ar&#x02013;OH)</td><td align="left">13.4, 22.9, 24.8, 29.8, 31.3, 46.6, 54.8, 116.9, 126.9, 130.7, 135.9, 148.9, 169.3, 189.9</td><td align="left">C, 69.96; H, 8.39; N, 11.66; (C, 69.91; H, 8.32; N, 11.64); 481</td></tr><tr><td align="left"><bold>T</bold><sub><bold>19</bold></sub></td><td align="left">2985 (C&#x02013;H str., aliphatic), 1650 (C=N str.), 1490 (C=C str., aromatic), 3099 (C&#x02013;H str., aromatic), 2572 (S&#x02013;H str.)</td><td align="left">1.29&#x02013;2.98 (s, 28H, CH<sub>2</sub>), 0.87 (s, 3H, CH<sub>3</sub>), 5.60&#x02013;7.06 (m, 3H, =CH),6.01&#x02013;7.69 (m, 6H, Ar&#x02013;H), 3.07 (s, H, SH)</td><td align="left">14.4, 22.1, 29.5, 31.2, 54.8, 116.9, 126.9, 130.7, 135.9, 148.6, 164.3, 189.6</td><td align="left">C, 70.86; H, 9.15; N, 12.71; (C, 70.82; H, 9.12; N, 12.62); 441</td></tr><tr><td align="left"><bold>T</bold><sub><bold>20</bold></sub></td><td align="left">2879 (C&#x02013;H str., aliphatic), 1648 (C=N str.), 2879 (C&#x02013;O&#x02013;C, str.), 1678 (C=C str., aromatic), 3156 (C&#x02013;H str., aromatic), 2572 (S&#x02013;H str)</td><td align="left">1.29&#x02013;2.52 (m, 28H, CH<sub>2</sub>), 0.84 (s, 3H, CH<sub>3</sub>), 6.30&#x02013;7.40 (m, 3H, Ar&#x02013;H), 3.07 (s, H, SH),</td><td align="left">14.7, 21.9, 25.8, 26.8, 31.1, 47.6, 54.5, 119.9, 130.1, 135.5, 158.9, 179.3, 188.9</td><td align="left">C, 65.31; H, 8.97; N, 13.85; (C, 65.28; H, 8.91; N, 13.80); 405</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec16"><title>Structure activity relationship (SAR) studies</title><p id="Par47">In the synthesized compounds, the substitution on <italic>m-</italic> and <italic>p</italic>-position of the aromatic ring with methoxy group improved the antimicrobial activity (compound <bold>T</bold><sub><bold>5</bold></sub>, MIC<sub><italic>BS</italic>,</sub>
<sub><italic>EC</italic></sub>&#x02009;=&#x02009;24.7&#x000a0;&#x000b5;M, MIC<sub><italic>PA</italic>,</sub>
<sub><italic>CA</italic></sub>&#x02009;=&#x02009;12.3&#x000a0;&#x000b5;M) against Gram positive (<italic>B. subtilis</italic>, <italic>P. aeruginosa</italic>), Gram negative (<italic>E. coli</italic>) bacterial and fungal (<italic>C. albicans</italic>) strains, respectively. The <italic>p</italic>-substitution of nitro (compound <bold>T</bold><sub><bold>17</bold></sub>, MIC<sub><italic>AN</italic></sub>&#x02009;=&#x02009;27.1&#x000a0;&#x000b5;M) group improved the antifungal activity against <italic>A. niger</italic>. The substituent methyl at <italic>p</italic>-position of ring (compound <bold>T</bold><sub><bold>3</bold></sub>, IC<sub>50</sub>&#x02009;=&#x02009;54.01&#x000a0;&#x000b5;g/ml) enhanced the anti-<italic>urease</italic> activity. The antioxidant activity has been improved by <italic>p</italic>-substituents i.e. aldehyde (compound <bold>T</bold><sub><bold>2</bold></sub>, IC<sub>50</sub>&#x02009;=&#x02009;34.83&#x000a0;&#x000b5;g/ml) and methyl groups (compound <bold>T</bold><sub><bold>3</bold></sub>, IC<sub>50</sub>&#x02009;=&#x02009;34.38&#x000a0;&#x000b5;g/ml). The most potent anticancer activity showed by compounds <bold>T</bold><sub><bold>2</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;3.84&#x000a0;&#x003bc;M) and <bold>T</bold><sub><bold>7</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;3.25&#x000a0;&#x003bc;M) against HCT116 cell lines as compared to standard 5-FU (IC<sub>50</sub>&#x02009;=&#x02009;25.36&#x000a0;&#x003bc;M). From the analysis of antimicrobial activity, it may be concluded that the substitution of methoxy group increase the antibacterial activity whereas introduction of nitro as electron withdrawing groups at <italic>p-</italic>position may enhance the antifungal activity of synthesized compounds. The introduction of methyl substituent as electron donating groups at <italic>p-</italic>position of aromatic ring may increase the anti-<italic>urease</italic> as well as antioxidant activity. The substitution of of <italic>p</italic>-aldehyde and <italic>o</italic>-hydroxy group on the aromatic ring may enhance the anticancer activity against HCT116 cells (Fig. <xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Structural requirements for antimicrobial, antioxidant and anti<italic>urease</italic> activity of 1,2,4-triazole derivatives</p></caption><graphic xlink:href="13065_2020_717_Fig3_HTML" id="MO15"/></fig></p></sec></sec><sec id="Sec2"><title>Experimental</title><p id="Par33">The initial material, reagents and solvents were purchased from Loba chemie. The glasswares were obtained from Borosil. The raw material was weighed on calibrated weighing balance. The synthetic scheme was drawn via ChemDraw 8.03. The confirmation of reaction at every step was done by TLC (thin layer chromatography). Melting point of the synthesized compounds was depicted by labtech melting point equipment. For spectral characterizations of the compounds, Bruker 12060280, Software: OPUS 7.2.139.1294 spectrometer using ATR for IR spectra (cm<sup>&#x02212;1</sup>) and Bruker Avance III at 600 NMR and 150&#x000a0;MHz for <sup>1</sup>H and <sup>13</sup>CNMR (DMSO-<italic>d6</italic>, &#x003b4; ppm) were used. The tested microbial strains like Gram positive, Gram negative bacteria and fungi were obtained from the Institute of Microbial Technology and Gene bank, Chandigarh for the in vitro antimicrobial activity. Waters Micromass Q-ToF Micro instrument was used for mass spectra. Elemental analysis was performed on Perkin-Elmer 2400 C, H and N analyzer and all synthesized compounds gave C, H and N analysis within&#x02009;&#x000b1;&#x02009;0.4% of the theoretical results.</p><sec id="Sec3"><title>Procedure for synthesized 1,2,4-triazole derivatives (T<sub>1</sub>&#x02013;T<sub>20</sub>)</title><sec id="Sec4"><title>Step A: synthesis of Int-i</title><p id="Par34">A mixture of palmitic acid (2.6&#x000a0;g, 0.01&#x000a0;mol), absolute ethanol (50&#x000a0;ml) and few drops of conc. sulphuric acid (0.5&#x000a0;ml) was refluxed for 10&#x000a0;h in a round bottom flask and then cooled to 5&#x000a0;&#x000b0;C. The liquid product was separated from reaction mixture by using ether on the basis of density and then purified [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec5"><title>Step B: synthesis of Int-ii</title><p id="Par35">To a solution of ethyl palmitate (<bold>Int-i</bold>, 2.8&#x000a0;g, 0.01&#x000a0;mol) in absolute ethanol (30&#x000a0;ml), hydrazine hydrate (0.64&#x000a0;g, 0.02&#x000a0;mol) was added and refluxed for 6&#x000a0;h and then left to cool. The solid product was collected by filtration and recrystallized from ethanol [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec6"><title>Step C: synthesis of Int-iii</title><p id="Par36">Palmitohydrazide (<bold>Int-ii</bold>, 3.12&#x000a0;g, 0.01&#x000a0;mol) dissolved in the solution of potassium hydroxide (1.12&#x000a0;g, 0.02&#x000a0;mol) in ethanol (30&#x000a0;ml) and then (0.76&#x000a0;g, 0.01&#x000a0;mol) carbon disulfide was added slowly in the reaction mixture. The reaction mixture was refluxed for 10&#x02013;12 hand then cooled at room temperature followed by addition of hydrochloric acid for neutralization of product. The precipitated solid was filtered, washed with ethanol, dried and recrystallized from ethanol [<xref ref-type="bibr" rid="CR27">27</xref>].</p></sec><sec id="Sec7"><title>Step D: synthesis of Int-iv</title><p id="Par37">An ethanolic (30&#x000a0;ml) solution of 5-pentadecyl-1,3,4-oxadiazole-2(3<italic>H</italic>)-thione (<bold>Int-iii</bold>, 3.26&#x000a0;g, 0.01&#x000a0;mol) and hydrazine hydrate (0.38&#x000a0;g, 0.01&#x000a0;mol) was heated under reflux for 3&#x000a0;h and then solution was poured in ice. The resulting product was filtered, washed and recrystallized from ethanol [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p></sec><sec id="Sec8"><title>Step E: synthesis of 1,2,4-triazole derivatives (T<sub>1</sub>&#x02013;T<sub>20</sub>)</title><p id="Par38">The reaction mixture of 4-amino-5-pentadecyl-4<italic>H</italic>-1,2,4-triazole-3-thiol (<bold>Int-iv</bold>, 3.26&#x000a0;g, 0.01&#x000a0;mol) and different substituted aldehydes (0.01&#x000a0;mol) in ethanol followed by addition of few drops of sulphuric acid was refluxed for an appropriate time. The reaction was monitored by thin layer chromatography. After completion of reaction, the product was poured in ice and filtered, then wash and finally solid products were collected and recrystallized from ethanol [<xref ref-type="bibr" rid="CR27">27</xref>].</p></sec></sec><sec id="Sec9"><title>Biological studies</title><sec id="Sec10"><title>Antimicrobial evaluation</title><p id="Par39">The in vitro antimicrobial screening of the synthesized 1,2,4-triazole derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>) in &#x003bc;M was determined against Gram-positive <italic>Bacillus subtilis</italic>, <italic>Pseudomonas aeruginosa</italic>, Gram-negative <italic>Escherichia coli</italic> bacterium and fungal strains <italic>Candida albicans</italic> and <italic>Aspergillus niger</italic> by tube dilution method using ciprofloxacin, amoxycillin (antibacterial) and fluconazole (antifungal) as reference drugs. DMSO was used to dissolve the reference and sample derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>). Dilutions were prepared in nutrient broth (I.P.) for bacterial (incubated at 37&#x02009;&#x000b1;&#x02009;1&#x000a0;&#x000b0;C for 24&#x000a0;h) and Sabouraud dextrose broth (I.P.) for fungal species (37&#x02009;&#x000b1;&#x02009;1&#x000a0;&#x000b0;C for 48&#x000a0;h for <italic>C. albicans</italic>) and (25&#x02009;&#x000b1;&#x02009;1&#x000a0;&#x000b0;C for 7&#x000a0;days for <italic>A. niger</italic>) (Table <xref rid="Tab3" ref-type="table">3</xref>, Figs. <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>) [<xref ref-type="bibr" rid="CR17">17</xref>].<table-wrap id="Tab3"><label>Table 3</label><caption><p>Antimicrobial screening results of the synthesized 1,2,4-triazole derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub><bold>)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="4">Compound</th><th align="left" colspan="5">Minimum inhibitory concentration (&#x000b5;M)</th></tr><tr><th align="left" colspan="3">Bacterial strain</th><th align="left" rowspan="2" colspan="2">Fungal strain</th></tr><tr><th align="left">Gram +ve</th><th align="left" colspan="2">Gram &#x02212;ve</th></tr><tr><th align="left"><italic>B. substilis</italic></th><th align="left"><italic>P. aeruginosa</italic></th><th align="left"><italic>E. coli</italic></th><th align="left"><italic>C. albican</italic></th><th align="left"><italic>A. niger</italic></th></tr></thead><tbody><tr><td align="left"><bold>T</bold><sub><bold>1</bold></sub></td><td align="left">120.5</td><td align="left">241.1</td><td align="left">241.1</td><td align="left">241.1</td><td align="left">120.5</td></tr><tr><td align="left"><bold>T</bold><sub><bold>2</bold></sub></td><td align="left">56.4</td><td align="left">56.4</td><td align="left">112.9</td><td align="left">225.9</td><td align="left">225.9</td></tr><tr><td align="left"><bold>T</bold><sub><bold>3</bold></sub></td><td align="left">58.3</td><td align="left">58.3</td><td align="left">116.6</td><td align="left">233.2</td><td align="left">116.6</td></tr><tr><td align="left"><bold>T</bold><sub><bold>4</bold></sub></td><td align="left">52.6</td><td align="left">52.6</td><td align="left">105.3</td><td align="left">52.6</td><td align="left">105.3</td></tr><tr><td align="left"><bold>T</bold><sub><bold>5</bold></sub></td><td align="left"><italic>24.7</italic></td><td align="left"><italic>12.3</italic></td><td align="left"><italic>24.7</italic></td><td align="left"><italic>12.3</italic></td><td align="left">99.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>6</bold></sub></td><td align="left">108.5</td><td align="left">54.2</td><td align="left">54.2</td><td align="left">108.5</td><td align="left">217.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>7</bold></sub></td><td align="left">116.1</td><td align="left">29.0</td><td align="left">116.1</td><td align="left">232.2</td><td align="left">232.2</td></tr><tr><td align="left"><bold>T</bold><sub><bold>8</bold></sub></td><td align="left">116.1</td><td align="left">58.0</td><td align="left">58.0</td><td align="left">116.1</td><td align="left">232.2</td></tr><tr><td align="left"><bold>T</bold><sub><bold>9</bold></sub></td><td align="left">54.6</td><td align="left">27.3</td><td align="left">54.6</td><td align="left">109.2</td><td align="left">218.4</td></tr><tr><td align="left"><bold>T</bold><sub><bold>10</bold></sub></td><td align="left">55.6</td><td align="left">55.6</td><td align="left">111.3</td><td align="left">222.6</td><td align="left">55.6</td></tr><tr><td align="left"><bold>T</bold><sub><bold>11</bold></sub></td><td align="left">55.6</td><td align="left">111.3</td><td align="left">111.3</td><td align="left">27.8</td><td align="left">111.3</td></tr><tr><td align="left"><bold>T</bold><sub><bold>12</bold></sub></td><td align="left">103.4</td><td align="left">51.7</td><td align="left">103.4</td><td align="left">206.8</td><td align="left">103.4</td></tr><tr><td align="left"><bold>T</bold><sub><bold>13</bold></sub></td><td align="left">101.3</td><td align="left">202.6</td><td align="left">202.6</td><td align="left">101.3</td><td align="left">202.6</td></tr><tr><td align="left"><bold>T</bold><sub><bold>14</bold></sub></td><td align="left">50.6</td><td align="left">101.3</td><td align="left">101.3</td><td align="left">202.6</td><td align="left">101.3</td></tr><tr><td align="left"><bold>T</bold><sub><bold>15</bold></sub></td><td align="left">54.3</td><td align="left">108.7</td><td align="left">217.5</td><td align="left">217.5</td><td align="left">54.3</td></tr><tr><td align="left"><bold>T</bold><sub><bold>16</bold></sub></td><td align="left">108.7</td><td align="left">108.7</td><td align="left">217.5</td><td align="left">217.5</td><td align="left">217.5</td></tr><tr><td align="left"><bold>T</bold><sub><bold>17</bold></sub></td><td align="left">54.3</td><td align="left">217.5</td><td align="left">217.5</td><td align="left">108.7</td><td align="left"><italic>27.1</italic></td></tr><tr><td align="left"><bold>T</bold><sub><bold>18</bold></sub></td><td align="left">104.0</td><td align="left">52.0</td><td align="left">104.0</td><td align="left">208.0</td><td align="left">104.0</td></tr><tr><td align="left"><bold>T</bold><sub><bold>19</bold></sub></td><td align="left">113.4</td><td align="left">226.9</td><td align="left">56.7</td><td align="left">113.4</td><td align="left">113.4</td></tr><tr><td align="left"><bold>T</bold><sub><bold>20</bold></sub></td><td align="left">61.7</td><td align="left">123.5</td><td align="left">61.7</td><td align="left">247.1</td><td align="left">247.1</td></tr><tr><td align="left"><bold>Fluconazole</bold></td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left"><italic>40.8</italic></td><td align="left"><italic>20.4</italic></td></tr><tr><td align="left"><bold>Ciprofloxacin</bold></td><td align="left"><italic>18.0</italic></td><td align="left"><italic>18.0</italic></td><td align="left"><italic>37.7</italic></td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left"><bold>Amoxicillin</bold></td><td align="left"><italic>17.1</italic></td><td align="left"><italic>17.1</italic></td><td align="left"><italic>17.1</italic></td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr></tbody></table><table-wrap-foot><p>Italics signifies the most active compound in comparison to the standard compound</p></table-wrap-foot></table-wrap><fig id="Fig4"><label>Fig. 4</label><caption><p>Antifungal screening results of synthesized derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>)</p></caption><graphic xlink:href="13065_2020_717_Fig4_HTML" id="MO3"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Antibacterial screening results of synthesized derivatives</p></caption><graphic xlink:href="13065_2020_717_Fig5_HTML" id="MO4"/></fig></p></sec><sec id="Sec11"><title>In vitro antioxidant evaluation</title><p id="Par40">In the DPPH free radical scavenging activity, compounds (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>) were evaluated for their free radical scavenging activity with ascorbic acid as standard compound. The IC<sub>50</sub> was calculated for each compound as well as ascorbic acid as standard and summarized in Table <xref rid="Tab4" ref-type="table">4</xref> and shown in Figs. <xref rid="Fig6" ref-type="fig">6</xref>, <xref rid="Fig7" ref-type="fig">7</xref>, <xref rid="Fig8" ref-type="fig">8</xref>. The scavenging effect increased with the increasing concentrations of sample compounds. DPPH is relatively stable nitrogen centered free radical that easily accepts an electron or hydrogen radical to become a stable diamagnetic molecule. DPPH radicals react with suitable reducing agents as a result of which the electrons become paired off forming the corresponding hydrazine. The solution therefore loses colour stoichometrically depending on the number of electrons taken up. Fifty millilitres of various concentrations (25, 50, 70 and 100&#x000a0;&#x000b5;g/ml) of the compounds dissolved in methanol was added to 5&#x000a0;ml of a 0.004% methanolic solution of DPPH. The sample solutions were incubated for 30&#x000a0;min at room temperature in dark place and after then absorbance was recorded against the blank solution at 517&#x000a0;nm. The relative percent of DPPH scavenging activity was calculated according to the following equation:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\text{I}}\% = \frac{{{\text{A}}_{{{\text{control}}}} - {\text{A}}_{{{\text{sample}}}} }}{{{\text{A}}_{{{\text{control}}}} }} \times 100, $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mtext>I</mml:mtext><mml:mo>%</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mtext>control</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>A</mml:mtext><mml:mtext>sample</mml:mtext></mml:msub></mml:mrow><mml:msub><mml:mtext>A</mml:mtext><mml:mtext>control</mml:mtext></mml:msub></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="13065_2020_717_Article_Equa.gif" position="anchor"/></alternatives></disp-formula><table-wrap id="Tab4"><label>Table 4</label><caption><p>Antioxidant screening results of the synthesized compounds (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub><bold>)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Compounds</th><th align="left" colspan="4">% inhibition</th><th align="left" rowspan="2">IC<sub>50</sub> (&#x000b5;g/ml)</th></tr><tr><th align="left">25 (&#x000b5;g/ml)</th><th align="left">50 (&#x000b5;g/ml)</th><th align="left">75 (&#x000b5;g/ml)</th><th align="left">100 (&#x000b5;g/ml)</th></tr></thead><tbody><tr><td align="left"><bold>T</bold><sub><bold>1</bold></sub></td><td char="." align="char">25.45</td><td char="." align="char">49.65</td><td char="." align="char">69.67</td><td char="." align="char">94.78</td><td char="." align="char">46.83</td></tr><tr><td align="left"><bold>T</bold><sub><bold>2</bold></sub></td><td char="." align="char">45.67</td><td char="." align="char">56.98</td><td char="." align="char">70.16</td><td char="." align="char">84.21</td><td char="." align="char"><italic>34.83</italic></td></tr><tr><td align="left"><bold>T</bold><sub><bold>3</bold></sub></td><td char="." align="char">43.56</td><td char="." align="char">60.12</td><td char="." align="char">75.67</td><td char="." align="char">88.98</td><td char="." align="char"><italic>34.38</italic></td></tr><tr><td align="left"><bold>T</bold><sub><bold>4</bold></sub></td><td char="." align="char">38.45</td><td char="." align="char">58.34</td><td char="." align="char">88.61</td><td char="." align="char">98.89</td><td char="." align="char">37.50</td></tr><tr><td align="left"><bold>T</bold><sub><bold>5</bold></sub></td><td char="." align="char">42.34</td><td char="." align="char">55.67</td><td char="." align="char">68.98</td><td char="." align="char">78.12</td><td char="." align="char">39.13</td></tr><tr><td align="left"><bold>T</bold><sub><bold>6</bold></sub></td><td char="." align="char">31.67</td><td char="." align="char">53.67</td><td char="." align="char">77.78</td><td char="." align="char">92.67</td><td char="." align="char">45.66</td></tr><tr><td align="left"><bold>T</bold><sub><bold>7</bold></sub></td><td char="." align="char">46.75</td><td char="." align="char">52.56</td><td char="." align="char">60.56</td><td char="." align="char">70.41</td><td char="." align="char">38.54</td></tr><tr><td align="left"><bold>T</bold><sub><bold>8</bold></sub></td><td char="." align="char">43.91</td><td char="." align="char">58.67</td><td char="." align="char">67.54</td><td char="." align="char">82.57</td><td char="." align="char">36.12</td></tr><tr><td align="left"><bold>T</bold><sub><bold>9</bold></sub></td><td char="." align="char">40.56</td><td char="." align="char">60.67</td><td char="." align="char">83.61</td><td char="." align="char">92.16</td><td char="." align="char">35.42</td></tr><tr><td align="left"><bold>T</bold><sub><bold>10</bold></sub></td><td char="." align="char">45.56</td><td char="." align="char">51.56</td><td char="." align="char">57.57</td><td char="." align="char">62.67</td><td char="." align="char">43.57</td></tr><tr><td align="left"><bold>T</bold><sub><bold>11</bold></sub></td><td char="." align="char">35.78</td><td char="." align="char">52.89</td><td char="." align="char">70.89</td><td char="." align="char">89.9</td><td char="." align="char">45.36</td></tr><tr><td align="left"><bold>T</bold><sub><bold>12</bold></sub></td><td char="." align="char">44.45</td><td char="." align="char">51.45</td><td char="." align="char">68.56</td><td char="." align="char">70.61</td><td char="." align="char">39.56</td></tr><tr><td align="left"><bold>T</bold><sub><bold>13</bold></sub></td><td char="." align="char">43.46</td><td char="." align="char">57.67</td><td char="." align="char">73.76</td><td char="." align="char">89.56</td><td char="." align="char">36.40</td></tr><tr><td align="left"><bold>T</bold><sub><bold>14</bold></sub></td><td char="." align="char">37.56</td><td char="." align="char">60.68</td><td char="." align="char">85.79</td><td char="." align="char">95.61</td><td char="." align="char">37.52</td></tr><tr><td align="left"><bold>T</bold><sub><bold>15</bold></sub></td><td char="." align="char">38.56</td><td char="." align="char">50.64</td><td char="." align="char">62.16</td><td char="." align="char">80.56</td><td char="." align="char">47.99</td></tr><tr><td align="left"><bold>T</bold><sub><bold>16</bold></sub></td><td char="." align="char">43.65</td><td char="." align="char">51.45</td><td char="." align="char">67.26</td><td char="." align="char">81.76</td><td char="." align="char">41.30</td></tr><tr><td align="left"><bold>T</bold><sub><bold>17</bold></sub></td><td char="." align="char">48.75</td><td char="." align="char">62.57</td><td char="." align="char">78.16</td><td char="." align="char">84.61</td><td char="." align="char">24.90</td></tr><tr><td align="left"><bold>T</bold><sub><bold>18</bold></sub></td><td char="." align="char">39.59</td><td char="." align="char">68.57</td><td char="." align="char">80.13</td><td char="." align="char">95.89</td><td char="." align="char">33.34</td></tr><tr><td align="left"><bold>T</bold><sub><bold>19</bold></sub></td><td char="." align="char">38.45</td><td char="." align="char">58.34</td><td char="." align="char">80.61</td><td char="." align="char">96.89</td><td char="." align="char">38.99</td></tr><tr><td align="left"><bold>T</bold><sub><bold>20</bold></sub></td><td char="." align="char">33.45</td><td char="." align="char">53.67</td><td char="." align="char">70.46</td><td char="." align="char">92.67</td><td char="." align="char">46.34</td></tr><tr><td align="left"><bold>Ascorbic acid</bold></td><td char="." align="char">38.67</td><td char="." align="char">63.68</td><td char="." align="char">84.78</td><td char="." align="char">94.45</td><td char="." align="char"><italic>35.44</italic></td></tr></tbody></table><table-wrap-foot><p>Italics signifies the most active compound in comparison to the standard compound</p></table-wrap-foot></table-wrap><fig id="Fig6"><label>Fig. 6</label><caption><p>% inhibition of ascorbic acid</p></caption><graphic xlink:href="13065_2020_717_Fig6_HTML" id="MO5"/></fig><fig id="Fig7"><label>Fig. 7</label><caption><p>% inhibition of most active compound <bold>T</bold><sub><bold>9</bold></sub></p></caption><graphic xlink:href="13065_2020_717_Fig7_HTML" id="MO6"/></fig><fig id="Fig8"><label>Fig. 8</label><caption><p>Antioxidant screening results of synthesized derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>)</p></caption><graphic xlink:href="13065_2020_717_Fig8_HTML" id="MO7"/></fig></p><p id="Par41">where A<sub>control</sub> is the absorbance of the control, A<sub>sample</sub> is the absorbance of the test compound.</p></sec><sec id="Sec12"><title>Urease inhibition evaluation</title><p id="Par42"><italic>Urease</italic> inhibitory potential for each synthesisized compound (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>) was evaluated using Jack Bean <italic>Urease</italic> by Indophenol method (Table <xref rid="Tab5" ref-type="table">5</xref>, Figs. <xref rid="Fig9" ref-type="fig">9</xref>, <xref rid="Fig10" ref-type="fig">10</xref>, <xref rid="Fig11" ref-type="fig">11</xref>). 250&#x000a0;&#x000b5;l of jack bean <italic>urease</italic> (4U) was mixed with 250&#x000a0;&#x000b5;l of different synthesized test compounds and standard of different concentrations [dissolved in DMSO/H<sub>2</sub>O mixture (1:1&#x000a0;v/v)]. The mixture was pre-incubated for 1&#x000a0;h at 37&#x000a0;&#x000b0;C in test tubes. 2&#x000a0;ml of 100&#x000a0;mM phosphate buffer (pH 6.8) containing 500&#x000a0;mM urea and 0.002% phenol red as an indicator were added in sample test tubes after pre incubation and again incubated at room temperature. Absorbance of reaction mixture was recorded by ELISA at 570&#x000a0;nm. Ammonium carbonate increased the pH of phosphate buffer from 6.8 to 7.7 which was produced from urea by <italic>urease</italic> enzyme and the end peak was measured by the colour of phenol red indicator [<xref ref-type="bibr" rid="CR16">16</xref>].<table-wrap id="Tab5"><label>Table 5</label><caption><p><italic>Urease</italic> inhibitory screening results of the synthesized compounds (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Compounds</th><th align="left" colspan="4">% inhibition</th><th align="left" rowspan="2">IC<sub>50</sub> (&#x000b5;g/ml)</th></tr><tr><th align="left">25 (&#x000b5;g/ml)</th><th align="left">50 (&#x000b5;g/ml)</th><th align="left">75 (&#x000b5;g/ml)</th><th align="left">100 (&#x000b5;g/ml)</th></tr></thead><tbody><tr><td align="left"><bold>T</bold><sub><bold>1</bold></sub></td><td char="." align="char">25.76</td><td char="." align="char">47.98</td><td char="." align="char">72.9</td><td char="." align="char">91.99</td><td char="." align="char">51.70</td></tr><tr><td align="left"><bold>T</bold><sub><bold>2</bold></sub></td><td char="." align="char">40.45</td><td char="." align="char">49.54</td><td char="." align="char">55.67</td><td char="." align="char">67.57</td><td char="." align="char">53.04</td></tr><tr><td align="left"><bold>T</bold><sub><bold>3</bold></sub></td><td char="." align="char">28.19</td><td char="." align="char">50.00</td><td char="." align="char">65.89</td><td char="." align="char">79.12</td><td char="." align="char"><italic>54.01</italic></td></tr><tr><td align="left"><bold>T</bold><sub><bold>4</bold></sub></td><td char="." align="char">35.45</td><td char="." align="char">49.45</td><td char="." align="char">63.67</td><td char="." align="char">79.45</td><td char="." align="char">50.52</td></tr><tr><td align="left"><bold>T</bold><sub><bold>5</bold></sub></td><td char="." align="char">23.34</td><td char="." align="char">44.35</td><td char="." align="char">70.87</td><td char="." align="char">90.87</td><td char="." align="char">54.46</td></tr><tr><td align="left"><bold>T</bold><sub><bold>6</bold></sub></td><td char="." align="char">38.45</td><td char="." align="char">50.34</td><td char="." align="char">65.61</td><td char="." align="char">80.89</td><td char="." align="char">47.02</td></tr><tr><td align="left"><bold>T</bold><sub><bold>7</bold></sub></td><td char="." align="char">23.98</td><td char="." align="char">46.89</td><td char="." align="char">76.09</td><td char="." align="char">91.90</td><td char="." align="char">52.07</td></tr><tr><td align="left"><bold>T</bold><sub><bold>8</bold></sub></td><td char="." align="char">22.45</td><td char="." align="char">39.58</td><td char="." align="char">68.58</td><td char="." align="char">92.67</td><td char="." align="char">56.43</td></tr><tr><td align="left"><bold>T</bold><sub><bold>9</bold></sub></td><td char="." align="char">33.45</td><td char="." align="char">53.67</td><td char="." align="char">70.46</td><td char="." align="char">92.67</td><td char="." align="char">46.34</td></tr><tr><td align="left"><bold>T</bold><sub><bold>10</bold></sub></td><td char="." align="char">27.90</td><td char="." align="char">46.89</td><td char="." align="char">70.90</td><td char="." align="char">89.80</td><td char="." align="char">51.90</td></tr><tr><td align="left"><bold>T</bold><sub><bold>11</bold></sub></td><td char="." align="char">25.00</td><td char="." align="char">42.45</td><td char="." align="char">68.88</td><td char="." align="char">92.67</td><td char="." align="char">54.59</td></tr><tr><td align="left"><bold>T</bold><sub><bold>12</bold></sub></td><td char="." align="char">43.56</td><td char="." align="char">46.57</td><td char="." align="char">52.56</td><td char="." align="char">61.56</td><td char="." align="char">58.06</td></tr><tr><td align="left"><bold>T</bold><sub><bold>13</bold></sub></td><td char="." align="char">26.57</td><td char="." align="char">48.78</td><td char="." align="char">73.98</td><td char="." align="char">98.89</td><td char="." align="char">50.05</td></tr><tr><td align="left"><bold>T</bold><sub><bold>14</bold></sub></td><td char="." align="char">41.70</td><td char="." align="char">46.23</td><td char="." align="char">50.49</td><td char="." align="char">57.78</td><td char="." align="char">67.02</td></tr><tr><td align="left"><bold>T</bold><sub><bold>15</bold></sub></td><td char="." align="char">29.03</td><td char="." align="char">37.14</td><td char="." align="char">61.78</td><td char="." align="char">73.12</td><td char="." align="char">61.04</td></tr><tr><td align="left"><bold>T</bold><sub><bold>16</bold></sub></td><td char="." align="char">45.76</td><td char="." align="char">49.10</td><td char="." align="char">53.87</td><td char="." align="char">59.12</td><td char="." align="char">52.85</td></tr><tr><td align="left"><bold>T</bold><sub><bold>17</bold></sub></td><td char="." align="char">37.91</td><td char="." align="char">42.38</td><td char="." align="char">57.61</td><td char="." align="char">71.42</td><td char="." align="char">57.47</td></tr><tr><td align="left"><bold>T</bold><sub><bold>18</bold></sub></td><td char="." align="char">40.90</td><td char="." align="char">46.79</td><td char="." align="char">55.89</td><td char="." align="char">67.9</td><td char="." align="char">54.30</td></tr><tr><td align="left"><bold>T</bold><sub><bold>19</bold></sub></td><td char="." align="char">31.89</td><td char="." align="char">47.98</td><td char="." align="char">52.98</td><td char="." align="char">65.87</td><td char="." align="char">63.24</td></tr><tr><td align="left"><bold>T</bold><sub><bold>20</bold></sub></td><td char="." align="char">28.98</td><td char="." align="char">49.09</td><td char="." align="char">69.09</td><td char="." align="char">81.90</td><td char="." align="char">52.34</td></tr><tr><td align="left"><bold>Thiourea</bold></td><td char="." align="char">29.98</td><td char="." align="char">46.76</td><td char="." align="char">67.78</td><td char="." align="char">76.78</td><td char="." align="char"><italic>54.25</italic></td></tr></tbody></table><table-wrap-foot><p>Italics signifies the most active compound in comparison to the standard compound</p></table-wrap-foot></table-wrap><fig id="Fig9"><label>Fig. 9</label><caption><p>% inhibition of the most active compound <bold>T</bold><sub><bold>3</bold></sub></p></caption><graphic xlink:href="13065_2020_717_Fig9_HTML" id="MO8"/></fig><fig id="Fig10"><label>Fig. 10</label><caption><p>% inhibition of thiourea</p></caption><graphic xlink:href="13065_2020_717_Fig10_HTML" id="MO9"/></fig><fig id="Fig11"><label>Fig. 11</label><caption><p><italic>Urease</italic> inhibitory screening results of the synthesized derivatives (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub>)</p></caption><graphic xlink:href="13065_2020_717_Fig11_HTML" id="MO10"/></fig></p><p id="Par43">The percentage inhibition of <italic>urease</italic> enzyme was calculated by using following formula:<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\text{I}}\% = \frac{{{\text{A }}_{{{\text{control}}}} {-}{\text{A }}_{{{\text{sample}}}} }}{{{\text{A }}_{{{\text{control}}}} }} \times 100, $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mtext>I</mml:mtext><mml:mo>%</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mtext>A</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>control</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mtext>A</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>sample</mml:mtext></mml:msub></mml:mrow><mml:msub><mml:mrow><mml:mtext>A</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>control</mml:mtext></mml:msub></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="13065_2020_717_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p><p id="Par44">where A<sub>control</sub> is the absorbance of the control; A<sub>sample</sub> is the absorbance of the test compound.</p></sec><sec id="Sec13"><title>Anticancer evaluation</title><p id="Par45">HCT116 (human colon cancer cells) were seeded at 2500&#x000a0;cells/well (96 well plate), allowed to attach overnight, exposed to the respective compounds for 72&#x000a0;h and subjected to SRB assay (570&#x000a0;nm). Data represent mean IC<sub>50</sub> of at least triplicates. The compounds were all dissolved in DMSO as stock of 100&#x000a0;mg/ml. DMSO of &#x0003c;&#x02009;1.5% did not result in cell kill. The highest concentration of each compound tested (100&#x000a0;&#x003bc;g/ml) contained only 0.1% DMSO. Compounds <bold>T</bold><sub><bold>2</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;3.84&#x000a0;&#x003bc;M) and <bold>T</bold><sub><bold>7</bold></sub> (IC<sub>50</sub>&#x02009;=&#x02009;3.25&#x000a0;&#x003bc;M) exhibited the most potent anticancer activity against HCT116 cell lines as compared to standard 5-FU (IC<sub>50</sub>&#x02009;=&#x02009;25.36&#x000a0;&#x003bc;M) given in Table <xref rid="Tab6" ref-type="table">6</xref> and Figs. <xref rid="Fig12" ref-type="fig">12</xref>, <xref rid="Fig13" ref-type="fig">13</xref>, <xref rid="Fig14" ref-type="fig">14</xref>.<table-wrap id="Tab6"><label>Table 6</label><caption><p>Anticancer screening results of the synthesized compounds (<bold>T</bold><sub><bold>1</bold></sub>&#x02013;<bold>T</bold><sub><bold>20</bold></sub><bold>)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Compounds</th><th align="left">IC<sub>50</sub> (&#x003bc;M)</th><th align="left">Compounds</th><th align="left">IC<sub>50</sub> (&#x003bc;M)</th></tr></thead><tbody><tr><td align="left"><bold>T</bold><sub><bold>1</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;241.16</td><td align="left"><bold>T</bold><sub><bold>12</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;206.80</td></tr><tr><td align="left"><bold>T</bold><sub><bold>2</bold></sub></td><td char="." align="char"><italic>3.84</italic></td><td align="left"><bold>T</bold><sub><bold>13</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;202.61</td></tr><tr><td align="left"><bold>T</bold><sub><bold>3</bold></sub></td><td char="." align="char">16.56</td><td align="left"><bold>T</bold><sub><bold>14</bold></sub></td><td char="." align="char">128.25</td></tr><tr><td align="left"><bold>T</bold><sub><bold>4</bold></sub></td><td char="." align="char">7.79</td><td align="left"><bold>T</bold><sub><bold>15</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;217.55</td></tr><tr><td align="left"><bold>T</bold><sub><bold>5</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;198.12</td><td align="left"><bold>T</bold><sub><bold>16</bold></sub></td><td char="." align="char">169.25</td></tr><tr><td align="left"><bold>T</bold><sub><bold>6</bold></sub></td><td char="." align="char">112.00</td><td align="left"><bold>T</bold><sub><bold>17</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;217.55</td></tr><tr><td align="left"><bold>T</bold><sub><bold>7</bold></sub></td><td char="." align="char"><italic>3.25</italic></td><td align="left"><bold>T</bold><sub><bold>18</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;208.02</td></tr><tr><td align="left"><bold>T</bold><sub><bold>8</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;232.20</td><td align="left"><bold>T</bold><sub><bold>19</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;226.91</td></tr><tr><td align="left"><bold>T</bold><sub><bold>9</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;218.47</td><td align="left"><bold>T</bold><sub><bold>20</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;247.15</td></tr><tr><td align="left"><bold>T</bold><sub><bold>10</bold></sub></td><td char="." align="char">173.90</td><td align="left"><bold>5-FU</bold></td><td char="." align="char"><italic>25.36</italic></td></tr><tr><td align="left"><bold>T</bold><sub><bold>11</bold></sub></td><td char="." align="char">&#x0003e;&#x02009;222.66</td><td align="left"><bold>DMSO</bold></td><td char="." align="char">1.50%</td></tr></tbody></table><table-wrap-foot><p>Italics signifies the most active compound in comparison to the standard compound</p></table-wrap-foot></table-wrap><fig id="Fig12"><label>Fig. 12</label><caption><p>IC<sub>50</sub> (&#x000b5;g/ml) of compound <bold>T</bold><sub><bold>2</bold></sub></p></caption><graphic xlink:href="13065_2020_717_Fig12_HTML" id="MO11"/></fig><fig id="Fig13"><label>Fig. 13</label><caption><p>IC<sub>50</sub> (&#x000b5;g/ml) of compound <bold>T</bold><sub><bold>7</bold></sub></p></caption><graphic xlink:href="13065_2020_717_Fig13_HTML" id="MO12"/></fig><fig id="Fig14"><label>Fig. 14</label><caption><p>IC<sub>50</sub> (&#x000b5;g/ml) of standard drug 5-FU</p></caption><graphic xlink:href="13065_2020_717_Fig14_HTML" id="MO13"/></fig></p></sec></sec></sec><sec id="Sec17"><title>Conclusion</title><p id="Par48">All the compounds were synthesized according to synthetic scheme under appropriate experimental conditions and analysed by elemental analysis, IR, mass, and <sup>1</sup>H/<sup>13</sup>CNMR. The pharmacological potential was evaluated to study the effect of different substituents on antimicrobial, antioxidant and anti-<italic>urease</italic> activities. From the outcomes of the pharmacological studies it can be concluded that the substitution of tri-methoxy (<bold>T</bold><sub><bold>5</bold></sub>) group increases the antibacterial activity whereas introduction of nitro (<bold>T</bold><sub><bold>17</bold></sub>) group at <italic>p-</italic>position enhances the antifungal activity. The introduction of aldehyde (<bold>T</bold><sub><bold>2</bold></sub>) and methyl (<bold>T</bold><sub><bold>3</bold></sub>) at <italic>p-</italic>position of aromatic ring may increase the anti-<italic>urease</italic> as well as antioxidant activities. The substitution of <italic>p</italic>-aldehyde (<bold>T</bold><sub><bold>2</bold></sub>) and <italic>o</italic>-hydroxy (<bold>T</bold><sub><bold>7</bold></sub>) groups on the aromatic ring may enhance the anticancer activity against HCT116 cell line.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>IR</term><def><p id="Par4">Infrared</p></def></def-item><def-item><term>NMR</term><def><p id="Par5">Nuclear magnetic resonance</p></def></def-item><def-item><term>BS</term><def><p id="Par6"><italic>Bacillus subtilis</italic></p></def></def-item><def-item><term>PA</term><def><p id="Par7"><italic>Pseudomonas aeruginosa</italic></p></def></def-item><def-item><term>EC</term><def><p id="Par8"><italic>Escherichia coli</italic></p></def></def-item><def-item><term>CA</term><def><p id="Par9"><italic>Candida albicans</italic></p></def></def-item><def-item><term>AN</term><def><p id="Par10"><italic>Aspergillus niger</italic></p></def></def-item><def-item><term>DPPH</term><def><p id="Par11">2,2-Diphenyl-1-picryl-hydrazyl-hydrate</p></def></def-item><def-item><term>MCF-7</term><def><p id="Par12">Michigan Cancer Foundation-7</p></def></def-item><def-item><term>HCT116</term><def><p id="Par13">Human colon cancer cell line</p></def></def-item><def-item><term>5-FU</term><def><p id="Par14">Fluorouracil</p></def></def-item><def-item><term>MIC</term><def><p id="Par15">Minimum inhibitory concentration</p></def></def-item><def-item><term>Cipro</term><def><p id="Par16">Ciprofloxacin</p></def></def-item><def-item><term>Amo</term><def><p id="Par17">Amoxycillin</p></def></def-item><def-item><term>Flu</term><def><p id="Par18">Fluconazole</p></def></def-item><def-item><term>IC<sub>50</sub></term><def><p id="Par19">Half maximal inhibitory concentration/median inhibitory concentration</p></def></def-item><def-item><term>SAR</term><def><p id="Par20">Structure activity relationship</p></def></def-item><def-item><term>DNA</term><def><p id="Par21">Deoxyribose nucleic acid</p></def></def-item><def-item><term>TLC</term><def><p id="Par22">Thin layer chromatography</p></def></def-item><def-item><term>ATR</term><def><p id="Par23">Attenuated total reflection</p></def></def-item><def-item><term>DMSO-d<sub>6</sub></term><def><p id="Par24">Di-methyl sulfoxide</p></def></def-item><def-item><term>ELISA</term><def><p id="Par25">Enzyme-Linked Immuno Sorbent Assay</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are thankful to Head, Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, for providing necessary facilities to carry out this research work.</p></ack><notes notes-type="author-contribution"><title>Authors' contributions</title><p>Authors MK, ST, BN and SK have designed synthesized and carried out the antimicrobial, antioxidant, anti-<italic>urease</italic> activities and KR, SML, SAAS and VM have carried out the spectral analysis, interpretation and anticancer evaluation of synthesized compounds. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par49">Not applicable.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par50">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname><given-names>MM</given-names></name><name><surname>Amarante</surname><given-names>TR</given-names></name><name><surname>Valente</surname><given-names>AA</given-names></name><name><surname>Almeida Paz</surname><given-names>FA</given-names></name><name><surname>Goncalves</surname><given-names>IS</given-names></name><name><surname>Pillinger</surname><given-names>M</given-names></name></person-group><article-title>A linear trinuclear oxidodiperoxido-molybdenum (vi) complex with single triazole bridges: catalytic activity in epoxidation, alcoholysis, and acetalization reactions</article-title><source>ChemCatChem</source><year>2018</year><volume>10</volume><issue>13</issue><fpage>2782</fpage><lpage>2791</lpage><pub-id pub-id-type="doi">10.1002/cctc.201800232</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>JH</given-names></name><name><surname>Irshaid</surname><given-names>FI</given-names></name><name><surname>Al-Soud</surname><given-names>YA</given-names></name><name><surname>Al-Balushi</surname><given-names>AM</given-names></name><name><surname>Al-Arqan</surname><given-names>HR</given-names></name></person-group><article-title>Synthesis, characterization and evaluation of antibacterial activity of six novel 1,2,4-triazole derivatives against standard and medical bacteria</article-title><source>Adv Stud Biol</source><year>2013</year><volume>5</volume><issue>6</issue><fpage>303</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.12988/asb.2013.3419</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asif</surname><given-names>M</given-names></name></person-group><article-title>A brief review on antitubercular activity of pharmacological active some triazole analogues</article-title><source>Glob J Res Rev</source><year>2014</year><volume>1</volume><issue>3</issue><fpage>51</fpage><lpage>58</lpage></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname><given-names>KT</given-names></name></person-group><article-title>The chemistry of 1,2,4-triazoles</article-title><source>Chem Rev</source><year>1961</year><volume>61</volume><issue>2</issue><fpage>87</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1021/cr60210a001</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalini</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Drabu</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>PK</given-names></name></person-group><article-title>Advances in synthetic approach to and antifungal activity of triazoles</article-title><source>Beilstein J Org Chem</source><year>2011</year><volume>7</volume><issue>1</issue><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.3762/bjoc.7.79</pub-id><pub-id pub-id-type="pmid">21804864</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonandi</surname><given-names>E</given-names></name><name><surname>Christodoulou</surname><given-names>MS</given-names></name><name><surname>Fumagalli</surname><given-names>G</given-names></name><name><surname>Perdicchia</surname><given-names>D</given-names></name><name><surname>Rastelli</surname><given-names>G</given-names></name><name><surname>Passarella</surname><given-names>D</given-names></name></person-group><article-title>The 1,2,3-triazole ring as a bioisostere in medicinal chemistry</article-title><source>Drug Discov Today</source><year>2017</year><volume>22</volume><issue>10</issue><fpage>1572</fpage><lpage>1581</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2017.05.014</pub-id><pub-id pub-id-type="pmid">28676407</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berova</surname><given-names>M</given-names></name><name><surname>Zlatev</surname><given-names>Z</given-names></name></person-group><article-title>Physiological response and yield of paclobutrazol treated tomato plants (<italic>Lycopersicon esculentum</italic> Mill.)</article-title><source>Plant Growth Regul.</source><year>2000</year><volume>30</volume><issue>2</issue><fpage>117</fpage><pub-id pub-id-type="doi">10.1023/A:1006300326975</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiller</surname><given-names>DS</given-names></name><name><surname>Fung</surname><given-names>HB</given-names></name></person-group><article-title>Posaconazole: an extended-spectrum triazole antifungal agent</article-title><source>Clin Ther</source><year>2007</year><volume>29</volume><issue>9</issue><fpage>1862</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2007.09.015</pub-id><pub-id pub-id-type="pmid">18035188</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>HC</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Recent researches in triazole compounds as medicinal drugs</article-title><source>Curr Med Chem</source><year>2012</year><volume>19</volume><issue>2</issue><fpage>239</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.2174/092986712803414213</pub-id><pub-id pub-id-type="pmid">22320301</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>BL</given-names></name><name><surname>Zhan</surname><given-names>YZ</given-names></name><name><surname>Zhang</surname><given-names>LY</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Synthesis and fungicidal activities of novel 1,2,4-triazole thione derivatives containing 1,2,3-triazole and substituted piperazine moieties</article-title><source>Phosphorus Sulfur Silicon Relat Elem</source><year>2016</year><volume>191</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1080/10426507.2015.1085040</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goss</surname><given-names>PE</given-names></name></person-group><article-title>Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor</article-title><source>Breast Cancer Res Treat</source><year>1998</year><volume>49</volume><issue>1</issue><fpage>S59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1023/A:1006052923468</pub-id><pub-id pub-id-type="pmid">9797019</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millson</surname><given-names>D</given-names></name><name><surname>Tepper</surname><given-names>S</given-names></name></person-group><article-title>Migraine pharmacotherapy with oral triptans: a rational approach to clinical management</article-title><source>Expert Opin Pharmacother</source><year>2000</year><volume>1</volume><issue>3</issue><fpage>391</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1517/14656566.1.3.391</pub-id><pub-id pub-id-type="pmid">11249525</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paeshuyse</surname><given-names>J</given-names></name><name><surname>Dallmeier</surname><given-names>K</given-names></name><name><surname>Neyts</surname><given-names>J</given-names></name></person-group><article-title>Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action</article-title><source>Curr Opin Virol</source><year>2011</year><volume>1</volume><issue>6</issue><fpage>590</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2011.10.030</pub-id><pub-id pub-id-type="pmid">22440916</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singhal</surname><given-names>N</given-names></name><name><surname>Sharma</surname><given-names>PK</given-names></name><name><surname>Dudhe</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name></person-group><article-title>Recent advancement of triazole derivatives and their biological significance</article-title><source>J Chem Pharm Res</source><year>2011</year><volume>3</volume><issue>2</issue><fpage>126</fpage><lpage>133</lpage></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>K</given-names></name><name><surname>Unver</surname><given-names>Y</given-names></name><name><surname>Unluer</surname><given-names>D</given-names></name><name><surname>Dugdu</surname><given-names>E</given-names></name><name><surname>Kor</surname><given-names>G</given-names></name><name><surname>Celic</surname><given-names>F</given-names></name><name><surname>Birinci</surname><given-names>E</given-names></name></person-group><article-title>Synthesis, characterization, and antioxidant activities of new tri-substituted triazoles</article-title><source>Turk J Chem</source><year>2012</year><volume>36</volume><fpage>457</fpage><lpage>466</lpage></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bektas</surname><given-names>H</given-names></name><name><surname>Ceylan</surname><given-names>S</given-names></name><name><surname>Demirba</surname><given-names>N</given-names></name><name><surname>Alpay-Karaoglu</surname><given-names>S</given-names></name><name><surname>Sokmen</surname><given-names>BB</given-names></name></person-group><article-title>Antimicrobial and antiurease activities of newly synthesized morpholine derivatives containing an azole nucleus</article-title><source>Med Chem Res</source><year>2013</year><volume>22</volume><issue>8</issue><fpage>3629</fpage><lpage>3639</lpage><pub-id pub-id-type="doi">10.1007/s00044-012-0318-1</pub-id><pub-id pub-id-type="pmid">23807823</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahlan</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Kakkar</surname><given-names>S</given-names></name><name><surname>Narasimhan</surname><given-names>B</given-names></name></person-group><article-title>Benzimidazole scaffolds as promising antiproliferative agents: a review</article-title><source>BMC Chem</source><year>2019</year><volume>13</volume><issue>1</issue><fpage>66</fpage><pub-id pub-id-type="doi">10.1186/s13065-019-0579-6</pub-id><pub-id pub-id-type="pmid">31384813</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingsbury</surname><given-names>KJ</given-names></name><name><surname>Paul</surname><given-names>S</given-names></name><name><surname>Crossley</surname><given-names>A</given-names></name><name><surname>Morgan</surname><given-names>DM</given-names></name></person-group><article-title>The fatty acid composition of human depot fat</article-title><source>Biochem J</source><year>1961</year><volume>78</volume><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1042/bj0780541</pub-id><pub-id pub-id-type="pmid">13756126</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>RG</given-names></name><name><surname>Hagerty</surname><given-names>MM</given-names></name><name><surname>McMahon</surname><given-names>KE</given-names></name></person-group><article-title>Lipids of human milk and infant formulas: a review</article-title><source>Am J Clin Nutr</source><year>1978</year><volume>31</volume><issue>6</issue><fpage>990</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1093/ajcn/31.6.990</pub-id><pub-id pub-id-type="pmid">352132</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AK</given-names></name><name><surname>Prachand</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name></person-group><article-title>Synthesis of some 4-amino-5-(substituted-phenyl)-4<italic>H</italic>-[1,2,4] triazole-3-thiol derivatives and antifungal activity</article-title><source>Int J Pharm Life Sci</source><year>2012</year><volume>3</volume><issue>7</issue><fpage>1848</fpage><lpage>1857</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Omar</surname><given-names>MA</given-names></name><name><surname>Al-Abdullah</surname><given-names>ES</given-names></name><name><surname>Shehata</surname><given-names>IA</given-names></name><name><surname>Habib</surname><given-names>EE</given-names></name><name><surname>Ibrahim</surname><given-names>TM</given-names></name><name><surname>El-Emam</surname><given-names>AA</given-names></name></person-group><article-title>Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles and related derivatives</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>2526</fpage><lpage>2550</lpage><pub-id pub-id-type="doi">10.3390/molecules15042526</pub-id><pub-id pub-id-type="pmid">20428062</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Serwy</surname><given-names>WS</given-names></name><name><surname>Mohamed</surname><given-names>NA</given-names></name><name><surname>Abbas</surname><given-names>EM</given-names></name><name><surname>Abdel-Rahman</surname><given-names>RF</given-names></name></person-group><article-title>Synthesis and anti-inflammatory properties of novel 1,2,4-triazole derivatives</article-title><source>Res Chem Intermed</source><year>2013</year><volume>39</volume><issue>6</issue><fpage>2543</fpage><lpage>2554</lpage><pub-id pub-id-type="doi">10.1007/s11164-012-0781-9</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plech</surname><given-names>T</given-names></name><name><surname>Kapron</surname><given-names>B</given-names></name><name><surname>Luszczki</surname><given-names>JJ</given-names></name><name><surname>Wujec</surname><given-names>M</given-names></name><name><surname>Paneth</surname><given-names>A</given-names></name><name><surname>Siwek</surname><given-names>A</given-names></name><name><surname>Nowak</surname><given-names>G</given-names></name></person-group><article-title>Studies on the anticonvulsant activity and influence on GABA-ergic neurotransmission of 1,2,4-triazole-3-thione-based compounds</article-title><source>Molecules</source><year>2014</year><volume>19</volume><issue>8</issue><fpage>11279</fpage><lpage>11299</lpage><pub-id pub-id-type="doi">10.3390/molecules190811279</pub-id><pub-id pub-id-type="pmid">25090118</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>BK</given-names></name><name><surname>Kitteringham</surname><given-names>NR</given-names></name><name><surname>Maggs</surname><given-names>JL</given-names></name><name><surname>Pirmohamed</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>DP</given-names></name></person-group><article-title>The role of metabolic activation in drug-induced hepatotoxicity</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2005</year><volume>45</volume><fpage>177</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.45.120403.100058</pub-id><pub-id pub-id-type="pmid">15822174</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asif</surname><given-names>M</given-names></name></person-group><article-title>Antivral and antiparasitic activities of various substituted triazole derivatives: a mini review</article-title><source>Chem Int</source><year>2015</year><volume>1</volume><issue>2</issue><fpage>71</fpage><lpage>80</lpage></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sayed</surname><given-names>R</given-names></name><name><surname>Khairou</surname><given-names>KS</given-names></name></person-group><article-title>Propoxylated fatty thiazole, pyrazole, triazole, and pyrrole derivatives with antimicrobial and surface activity</article-title><source>J Surfactants Deterg</source><year>2015</year><volume>18</volume><issue>4</issue><fpage>661</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1007/s11743-015-1684-8</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sayed</surname><given-names>R</given-names></name></person-group><article-title>Synthesis, antibacterial and surface activity of 1,2,4-triazole derivatives</article-title><source>Grasas Aceites</source><year>2006</year><volume>57</volume><issue>2</issue><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.3989/gya.2006.v57.i2.35</pub-id></element-citation></ref></ref-list></back></article>